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Abstract 
 
The role of adenosine monophosphate activated kinase in luteal progesterone 
production  
 
Elizabeth Compton Bowdridge  
 
Prostaglandin F2 alpha (PGF2α) has in vivo luteolytic actions on the bovine corpus luteum 
(CL).  Although PGF2α is utilized extensively in livestock to synchronize estrus, its 
actions in vitro are controversial and do not always result in a reduction in progesterone 
(P4) secretion.  The mechanism of action of PGF2α is thought to involve activation of the 
phospholipase C-Ca2+ pathway.  The luteolytic actions of PGF2α are mediated through an 
elevation of cytosolic Ca2+ involving activation of protein kinase C (PKC).  Expression of 
PKC isozymes and calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) 
change as the CL develops to a mature stage. Either CAMKK2 directly affects 
steroidogenesis or works indirectly through an intermediary step, such as adenosine-
monophosphate kinase (AMPK), which is activated through CAMKK2 targeted 
phosphorylation.  Specifically, the hypothesis that activation of PGF2α receptor (FP) in 
the mature CL involves AMPK was examined.  Expression of mRNA encoding a 
potential target AMPK for the action of CAMKK2, was increased in the mature versus 
developing CL.  Furthermore, activation of FP induced rapid phosphorylation of AMPK.  
An AMPK-specific inhibitor, dorsomorphin dichloride (DM), eliminated effects of 
PGF2α on secretion of P4, supporting the hypothesis that activation of the FP receptor in 
mature CL involves participation of AMPK.  Furthermore, in vitro two AMPK activators, 
5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and metformin, decreased 
basal P4 secretion in mature but not in developing CL.  Effect of FP activation on 
cholesterol transport in the mature CL was investigated.  Both serum and luteal P4 
declined as soon as 2 hours after PGF2α administration, which was paralleled by a 
decrease in protein concentration of low density lipoprotein receptor (LDLR).  Human 
mural granulosal cells are collected routinely when a patient is undergoing in vitro 
fertilization (IVF) and are useful for studying granulosal lutein cells of the CL.  Altering 
intracellular calcium in these cells through an ionophore, A23187, increased basal P4 
production.  However, at high concentrations a calcium chelator, BAPTA, decreased P4 
from mural granulosal cells.  Infertility is a problem that affects more than 6.1 million 
women and their partners across the United States.  Causes of infertility range from 
female related tubal factors such as blockage, endometriosis, diminished ovarian reserve, 
to male related infertility due to abnormal sperm motility or morphology to unexplained 
infertility.  Primary infertility types, age, BMI, and pregnancy outcome influenced ability 
of granulosal cells to increase P4 production when stimulated with human chorionic 
gonadotropin (hCG).  AICAR decreased basal P4 production in these cells, which is 
similar to earlier observations in the mature bovine CL.  Thus, AMPK appears to be a 
distal target in the pathway responsible for mediating the actions of PGF2α.  Directly 
activating AMPK could lead to better estrous cycle manipulation in the cow, or 
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Chapter 1: Literature Review 
Introduction  
Follicles, composed of the oocyte, granulosal and thecal cells, are the functional unit of 
the ovary.  The somatic cells in the outermost vascular portion of the follicle include thecal and 
myoepithelial cells.  Myoepithelial cells aid in rupture of the follicle during ovulation by 
increasing intrafollicular pressure through contraction.  At least two populations of thecal cells 
are recognized: theca interna and theca externa.  The theca interna expresses luteinizing hormone 
(LH) receptor and produces androstenedione, but does not contain aromatase, the enzyme needed 
for conversion of androstendione to estrogen, which is expressed in granulosal cells (Hseuh et 
al., 1984).  The avascular component of the follicle is delimited by a basement membrane upon 
which the other somatic cells of the follicle, the granulosal epithelial layer and the germ cell 
reside.  Two populations of granulosal cells have been identified: mural and cumulus granulosal 
cells.  Both populations of cells are organized as a stratified epithelium with the basal layer of 
mural cells contacting the basement membrane adjacent to the thecal cells and the cumulus cells 
surrounding the oocyte (Buccione et al., 1990).  The 2-cell, 2-gonadotropin theory was first 
suggested 50 years ago (Short, 1961).  The theory is essential in understanding the role that these 
two types of granulosal cells play in estrogen secretion from the growing follicle (Liu and Hsueh, 
1986).  In most mammalian species, formation of a follicular antrum, a fluid filled form of 
extracellular matrix (ECM; Rogers and Rogers, 2010), divides these two populations of 
granulosal cells.  Presumably, the antrum is formed by an osmotic gradient that draws fluid from 
the vasculature that is adjacent to the thecal cell population (Rogers and Rogers, 2010).  
Granulosal cells produce both hyaluronan and versican, and these two molecules contribute to 
cumulus cell expansion (Rogers and Rogers, 2010).  After antrum formation, mural granulosal 
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cells express both FSH and LH receptor as well as 3β-HSD and P450 SCC (Zoller and Weisz, 
1979) the expression of these two enzymes is more a luteal feature in these cells.  Cumulus 
granulosal cells remain with the oocyte after ovulation and respond to the ovulatory LH surge by 
assembling another specialized ECM by a process known as cumulus expansion (Russell and 
Salustri, 2006).  This unique set of somatic cells possess an epithelial phenotype and are tightly 
connected to one another via intercellular processes, known as gap junctions, which allow for 
passage of small molecules that regulate signaling and metabolism by the oocyte (Russell and 
Salustri, 2006).  This subset of granulosal cells has a gene expression profile that is specific for 
cumulus cell expansion, which distinguishes them from mural granulosal cells, which do not 
undergo expansion.  Once ovulation has occurred, mural granulosal cells lose their ability to 
proliferate, undergo epithelial-mesenchyme transition and differentiate into the large luteal cells 
(LLC) of the corpus luteum (CL), which secrete high concentrations of basal progesterone 
(Chaffkin et al., 1992).  Theca cells become small luteal cells (SLC) once luteinization has 
occurred.  In the primate, the granulosal and thecal cells remain as two distinct populations and 
are separated by the remnants of the follicular basement membrane (Guraya, 1971).  In contrast, 
the basement membrane separating these two cell populations is degraded, and thecal cells 
invade the granulosa to form a heterogeneous mixture of cells in the CL of nonprimate species 
(Niswender, 2000). 
Development of the bovine corpus luteum 
Neovascularization   
The CL is a transient endocrine organ that begins to form immediately after ovulation and 
requires extensive neovascularization to ensure both structural and functional development.  
During the first eight to ten days of growth, the CL doubles in size and cell number every 60-70 
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hours (Reynolds et al., 1994).  This rate of growth is comparable to the fastest growing tumors, 
yet, unlike tumors, cell proliferation in the CL is self-limiting and tightly regulated (Reynolds et 
al., 1994).  Ovulated follicular tissues of approximately 40 mg grow to 600-700 mg of CL tissue 
within a few days (Reynolds, 2000).  This growth can be attributed to hyperplasia of SLC, 
fibroblasts, and endothelial cells, as well as hypertrophy LLCs without hyperplasia in the ovine 
CL (Farin et al., 1986).  However, in vitro both hypertrophy and hyperplasia occur in bovine 
luteal steroidogenic cells as measured by cell cycle (cyclin D2 and E1) and cell proliferation  
(Ki-67) genes (Yoshioka et al., 2013).  To support such extensive cell growth, angiogenesis 
occurs rapidly and reaches a maximum 2 to 3 days after ovulation (Reynolds, 2000).  This 
change is reflected by the fact that approximately 50-85% of the luteal cell proliferation occurs 
in the microvasculature unit, and endothelial cells and pericytes make up over half of the cell 
population in the mature CL (Reynolds et al., 1994).  Increased vascularization enables the CL to 
receive more blood flow per unit of tissue than any other mature organ in the body (Reynolds, 
2000).  Most membranes of luteal cells are either adjacent to capillaries or adjacent to the 
interstitial space that is in close proximity to capillaries (Dharmarajan et al., 1985).  Inadequate 
or subfunctional luteal development is known to occur in cattle (Redmer & Reynolds, 1996) and 
in humans (Reynolds et al., 2000) and is associated with reduced vascularization in both cases. 
 Several angiogenic factors contribute to the vascularization of the bovine CL.  Two key 
mediators in neovascularization are fibroblast growth factor 2 (FGF2) and vascular endothelial 
growth factor (VEGF) A (Robinson et al., 2009).  Both VEGF and its receptors VEGFR1 and 
VEGFR2 mRNA are expressed in the bovine CL and endothelial cells (Berisha et al., 2000).  
Additionally, VEGF is a mitogen for endothelial cells, and its expression is induced by the 
preovulatory LH surge (Garrido et. al, 1993).  In the cow, FGF2 protein synthesis occurs in 
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endothelial cells and pericytes of the thecal layer occur prior to the LH surge and in the 
luteinizing granulosa mainly after ovulation (Berisha et al., 2006).  After a few days FGF2 was 
absent from all steroidogenic cells but reappeared in endothelial cells (Berisha et al., 2006).  
Both endothelial cells (Robinson et al., 2008) and pericytes (Robinson et al., 2007) are targets for 
multiple angiogenic factors.  Pericytes appear to play a dual role in neovascularization.  First 
they act as a guide for the outgrowth of endothelial cells, and secondly they help stabilize newly 
formed vessels (Robinson et al., 2009).  Changes in mRNA and protein expression in FGF2 that 
occur after the LH surge imply that FGF2 is crucial for the follicle-luteal transition in cattle 
(Robinson et al., 2007).  The LH surge had no effect on VEGF concentrations, so VEGF is 
thought to play a constitutive, but essential, role in the development of luteal vasculature 
(Robinson et al., 2007).  Both factors and their receptors are expressed at higher concentrations 
in the developing bovine CL and decrease significantly in the maintenance to regressing CL 
(Schams et al., 1994; Berisha et al., 2000). 
Small and large luteal cells 
Two morphologically distinct steroidogenic cells types comprise CL of cattle, sheep and 
many other mammalian species (Niswender and Nett, 1994).  Small luteal cells  
(18-20 µm) are derived from the thecal cells of the follicle, contain receptor for luteinizing 
hormone (LH), respond to LH by producing cAMP and increasing secretion of progesterone, and 
usually contain multiple lipid droplets (Niswender, 2002).  The number of SLC increased  
four-fold from day 4 to day 8 in the estrous cycle of the ewe, but these cells maintained a 
constant volume (Farin et al., 1986).  Large luteal cells (25-40 µm) originate from granulosal 
cells, secrete high basal concentrations of progesterone, and have receptors for both LH and 
PGF2α (Niswender, 2002).  Numbers of LLC did not change throughout the estrous cycle of the 
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ewe but volume and diameter increased until day 16 of the cycle (Farin et al., 1986).  Basal 
secretion of progesterone differs between these two luteal cell types with LLC producing 2-40 
times more progesterone than SLC (Niswender et al., 2000).  Both LLC and SLC differ in their 
response when stimulated with hormones and/or intracellular mediators.  Physiological 
concentrations of LH increased secretion of progesterone from bovine SLC but not LLC in vitro 
(Alila et al., 1998).  Steroidogenic cells in the CL synthesize large amounts of progesterone.  
Increased synthesis of progesterone occurs as the CL develops and is maintained if a pregnancy 
is established, or is abolished due to CL regression. 
Progesterone production  
All steroids, including progesterone, are derived from cholesterol, which can come from 
the plasma membrane, cellular stores (lipid droplets), lipoproteins (low density lipoproteins 
[LDL] and high density lipoproteins [HDL]), and de novo synthesis (Hu et al., 2010).  Each LDL 
particle contains approximately 2500 cholesterol molecules, which makes this pathway very 
efficient for progesterone production.  Uptake of LDL by luteal cells occurs by receptor-
mediated endocytosis (Hu et al., 2010).  During this process, LDL binds to its plasma membrane 
(PM) bound receptor, which then translocates to specialized regions of the PM called coated pits 
to invaginate and pinch off to form clathrin-coated vesicles (Hu et al., 2010).  These vesicles 
rapidly fuse with lysosomes where the protein of the LDL is hydrolyzed to amino acids and 
cholesteryl esters are hydrolyzed by a lysosomal acid lipase (Brown and Goldstein, 1979).  The 
LDL-receptor complex rapidly dissociates with the full intact LDL-receptor being sorted and 
returned to the PM.  The resulting cholesterol from the LDL particle can be released and 
transported to the mitochondria for steroid hormone synthesis (Hu et al., 2010) or undergo 
esterification by A:cholesterol acyltransferase 1 (ACAT1).  Additionally, ACAT1 is responsible 
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for esterification of de novo synthesized cholesterol.  Cholesterol esters are stored in lipid 
droplets, which have been shown to be hormonally regulated in steroidogenic cells of the 
adrenal, ovary and testis (Behrman and Greep, 1972; Hu et al., 2010).  
The HDL is taken up by the cell by binding to the plasma membrane-bound HDL binding 
protein (Lestavel and Fruchart, 1994), and cholesterol is mobilized into the cell by an undefined 
mechanism.  Free cholesterol is transported to the mitochondria along the cytoskeletal network 
and by sterol carrier proteins where it is then transported from the outer to inner mitochondrial 
membrane by steroidogenic acute regulatory protein (StAR) (Niswender, 2002).  Cholesterol is 
converted to pregnenolone by an inner mitochondrial enzyme, cytochrome P450 side chain 
cleavage (P450scc). Pregnenolone travels out of the mitochondria and is converted to 
progesterone by the smooth endoplasmic reticulum enzyme 3β-hydroxysteroid dehydrogenase 
(3β-HSD) (Niswender, 2002).  Additionally, peripheral-type benzodiazepine receptors (PBR) 
may play a role in cholesterol transport as it is moved from the outer to inner mitochondrial 
membranes (Niswender, 2002).  Targeted deletion of the PBR from Leydig cells drastically 
reduced steroid secretion, and reintroduction of PBR allowed steroid secretion to be restored 
(Papadopoulos et al., 1997).  Additionally, phosphorylation of PBR by protein kinase A (PKA) 
enhanced cholesterol transport (Papadopoulos et al., 1997).  It is possible that PBR works as a 
cholesterol channel.   
Luteinization of human mural granulosal cells 
During follicular development granulosal cells primarily secrete estrogen (E2), but as 
ovulation approaches they begin to produce progesterone (P4).  During the preovulatory period 
E2 secretion is drastically reduced, and granulosal cells begin to synthesize P4 (McNatty et al., 
1979). Additionally, these cells undergo loss of aromatase and mitotic activity (Robertson and 
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Baker, 1969; Friedrich et al., 1975).  Interestingly, P4 receptors (PGR) cannot be detected with 
immunohistochemical analysis in human granulosal cells at any follicular stage but are detected 
readily in human luteal tissue (Suzuki et al., 1994).  This finding supports the hypothesis that LH 
induces PGR expression (Hild-Petito et al., 1988). 
Human granulosal cells recovered during oocyte retrieval in patients undergoing in vitro 
fertilization have been shown to luteinize in culture and, therefore, have been used as a model to 
study granulosal lutein cells of the CL (Stewart and Vandevoort, 1997).  This model has several 
advantages: no collagenases or other proteolytic enzymes that may influence hormone secretions 
are needed for cell isolation; unlike ovarian cell line cultures, primary granulosal cell cultures 
retain their ability to produce and respond to steroid hormones; and serum-free media can be 
used to examine circulating hormones or serum-derived factors (Hsueh et al., 1984).  This model 
has limitations: absence of vascularization and the influence of angiogenic factors; inability of 
other follicular cell types such as theca interna or oocyte-cumulus cells to influence granulosal 
cell differentiation (Hsueh et al., 1984); and representative of only one stage of development of 
the CL (which has not been clearly defined) and do not take into account the heterogeneity of a 
granulosal cell population or the fertility status of the patient from which they were isolated.   
Luteotropic versus luteolytic signals  
Luteotropic hormones  
Luteotropic hormones support the growth and/or function of the CL.  Luteinizing 
hormone (LH), growth hormone (GH), prolactin, insulin-like growth factor 1 (IGF-1), 
prostaglandin (PG) E2 (PGE2) and prostacyclin (PGI2) are all luteotropic hormones.  In order to 
increase P4 LH acts on the SLC of most species and the LLC in pregnant and pseudopregnant 
rats as well as nonhuman primates (Hild-Petito et al., 1989; Niswender et al., 2000).  Most 
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luteotropic hormones work by initiating the same intracellular mediator cascade.  For example in 
bovine luteal tissue or cells, LH binds to its G-protein-coupled receptor in SLC and activates 
adenylate cyclase, which increases concentrations of cyclic adenosine monophosphate (cAMP) 
and activates PKA (Hoyer et al., 1984).  Increase in P4 is achieved through increased transport of 
cholesterol to the P-450 SCC enzyme complex to the mitochondria (Wiltbank et al., 1993).  The 
LLC also express LH receptor but secrete more basal P4 than SLC, so an increase in response to 
LH may be due to constitutively expressed PKA (Hoyer et al., 1984).   
Luteolytic hormones 
Luteolytic hormones promote luteal regression.  In many species, including cattle, PGF2α 
is the primary uterine factor responsible for functional and structural luteolysis (McCracken, 
1971).  Additionally, oxytocin and luteal PGF2α play roles in luteolysis.  Increases in protein 
kinase C (PKC) enzyme activity and intracellular calcium mediate the anti-steroidogenic effects 
of PGF2α (Niswender et al., 2000).  In fact, PGF2α-induced accumulation of extracellular 
calcium in the cytosolic compartment enhances PKC enzyme activity (Niswender, 2000).   
Metabolism and actions of intraluteal PGs, including but not limited to PGF2α, affect the 
lifespan of the CL.  Actions of luteal-derived PGF2α are likely mediated by the G-protein coupled 
plasma membrane receptor, FP, that uterine PGF2α acts on (Wiltbank and Ottobre, 2003).  
Expression of FP receptor mRNA is present at 100-fold greater concentrations in the CL than in 
any other tissue, EP3 receptor is also expressed (Anderson et al., 2001).  Koybayashi et al. 
(2001) found that developing bovine CL (day 3) produce more PGF2α than mid phase CL (days 
4-6).  In agreement with those results, luteal concentrations of cyclooxygenase-2 (COX-2) 
mRNA were greater in the developing than mature to regressing CL.  Additionally, PGF2α 
increased the availability of arachidonic acid (AA) and COX-2 activity, both essential for PG 
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production in the CL (Niswender et al., 2000).  This evidence supports the ability of PGF2α to 
regulate its own production in the CL.  However, a temporal relationship exists in the ratio of 
luteotropic (PGI2) and luteolytic (PGF2α) PGs throughout the estrous cycle (Milvae and Hansel, 
1983).  Luteal PGs are stimulated by cytokines such as INFγ (Fairchild and Pate, 1991) and 
TNFα (Benyo and Pate, 1992) but suppressed by high intraluteal concentrations of progesterone 
(Pate, 1988).  Although uterine-derived PGF2α is the main luteolytic factor in ruminants, other 
PGs appear to play a role in determining the lifespan of the CL. 
 Luteal regression is not mediated by uterine PGF2α in primates (Beling, 1970).  Infusion 
of PGF2α directly into the CL reduced P4 and caused premature menses in monkeys (Auletta et 
al., 1984).  It has been suggested that luteal-derived PGF2α acts in a paracrine and/or autocrine 
manner to induce luteal regression (Auletta and Flint, 1988).  Despite this evidence, the source 
and actions of PGF2α in the primate still remain controversial. 
Oxytocin is secreted mainly by the posterior pituitary during and after parturition and 
lactation in order for milk letdown to occur, but also it is an important factor during luteal 
regression.  Flint and Sheldrick (1982) showed that a rapid increase of ovarian oxytocin was 
elicited within five minutes of administering a PGF2α analogue (Estrumate®, 125 µg i.m.).  In 
part due to this finding, McCracken et al. in 1996 suggested that the initiating factor for 
luteolysis is stimulation of posterior pituitary oxytocin by E2 or the removal of P4 (McCracken et 
al., 1996), which in turn stimulate secretion of uterine PGF2α (Fairclough et al., 1980).  This 
cascade leads to a positive feedback loop that causes the release of luteal oxytocin as well as 
luteal and more uterine PGF2α (Silvia et al., 1991) leading to luteal regression.  One explanation 
for the time between pulses of naturally occurring uterine PGF2α is refractoriness of the uterus to 
oxytocin.  However, depletion of oxytocin or its receptors in the bovine CL did not delay 
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luteolysis (Kotwica and Skarzynksi, 1999), implying that it is not critical for luteal regression.  
The role of oxytocin in luteal regression remain controversial. 
Signals for maintenance of corpora lutea  
 During gestation, maternal recognition of pregnancy must occur so that P4 synthesis and 
secretion continue uninterrupted.  Considerable variation exists among species, but, in general, 
the conceptus secretes factors that are anti-luteolytic (anti-PGF2α) or luteotropic (Roberts et al., 
1996) to maintain the CL and P4 secretion.  In the case of the human, [human] chorionic 
gonadotropin (hCG) is secreted by the trophoblastic cells of the implanting embryo (Hearn et al., 
1991) and binds to the LH receptors in the CL to increase P4 secretion as well to protect the CL 
from PGF2α (Patton and Stouffer, 1991).  In contrast, in the cow, secretion of the protein 
interferon tau (IFτ) by the trophectoderm of the elongating blastocyst has been postulated to 
suppress the pulsatile release of PGF2α from the uterus (Roberts et al., 1996).   
During a non-fertile luteal phase, luteotropic signals allow the CL to increase in size and 
ability to secrete P4 (Niswender et al., 2000).  However, if a pregnancy is not established, the CL 
must regress in order for another follicle to grow, ovulate, and a new cycle begin.  As mentioned 
earlier, uterine PGF2α is the luteolytic signal in ruminants.  In the cow, both large and small 
luteal cells are capable of responding to PGF2α with an increase in intracellular Ca+2 (Choudhary 
et al., 2004).  The binding of PGF2α to its receptor in these luteal cells activates two pathways 
that affect steroidogenesis in the CL.  The first is activation of PKC, which directly inhibits 
progesterone production (Niswender, 2002).  Additionally, increases in free intracellular Ca+2 
lead to apoptosis and cell death (Wiltbank et al., 1989).  In primates, the role of PGF2α is 
controversial but may play a role when it is of ovarian origin.  Due to these actions PGF2α is 
utilized extensively in livestock species to synchronize estrus.  However, the bovine CL is 
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resistant to luteal regression by exogenous PGF2α before day 5 (D 5) of the estrous cycle.   
Estrous synchronization protocols  
The discovery of PGF2α as the luteolysin in ruminant species led to an explosion of 
synchronization protocols specifically in dairy cattle (Pursley et al. 1995).  Synchronizing estrus 
with exogenous PGF2α allowed for more easily detecting estrus in large herds as well as more 
efficient artificial insemination (AI) programs (Stevenson and Pursley, 1994).  Originally, PGF2α 
was given twice, 11 days apart (Lucy et al., 1986).  However, it was found that while 60% of 
cows responded to the first PGF2α injection by CL regression only 72% responded to the second 
injection when all animals should have had CL older than 5 days (Lucy et al., 1986).  Due to 
variabilty in time to estrus and low conception rates for fixed time AI, GnRH was incorporated 
into estrous synchronization protocols in order to initiate a new follicular wave with a dominant 
follicle prior to PGF2α and to more tightly synchronize ovulation 24 hours before breeding 
(Pursley et al., 1995).   
Responsiveness of corpora lutea to PGF2α 
The ability of the CL to respond to the luteolytic actions of PGF2α increases with 
maturation in cattle.  The developing CL (days 1-5) will not regress if a single administration of 
PGF2α is given, but in the mature CL (days 6-15), the same dose of exogenous PGF2α, will 
induce regression, and the cow will come into estrus within 48-72 hours (Rowson, Tervit and 
Brand, 1972; Inskeep, 1973).  However, differences in response to PGF2α have been noted across 
timespans during the mature phase of the CL.  In 1984, Tanabe and Hann administered a single 
injection of PGF2α on days 7, 11, or 15 of the estrous cycle in heifers and found that the 
percentage of heifers exhibiting synchronized estrus at 80 hours afer PGF2α tended to increase 
with stage of estrous cycle (day 7-86%, day 11-90%, and day 15-98%).  This area of research has 
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been under intensive investigation for many years, but the mechanism for the developmental 
difference is still not understood.  However, lack of receptors (Wiltbank, 1995; Wright et al., 
2014) or the ability of PGF2α to produce physiological responses (Tsai and Wiltbank, 1998; Sen 
et al., 2005) do not explain this difference in the developing CL.  
Normal versus induced corpora lutea 
There is evidence that a CL formed after a spontaneous ovulation is characteristically 
different than one formed when the previous CL is regressed by pharmaceutical methods.  In a 
study by Keisler and Keisler in 1989, CL that were induced in the absence of an existing CL 
were short-lived whereas CL that were induced during the luteal phase of the estrous cycle did 
not affect lifespan of spontaneous CL.  However, in Brahman cattle, no difference in CL weight, 
progesterone content, or number of LH receptors were found between spontaneous and induced 
CL (Hansen et al., 1987).  .   
 In multiple species, PGF2α elicits both inhibitory and stimulatory responses to P4 in luteal 
cells in vitro.  Most investigators used a non-physiological dose of PGF2α when treating luteal 
cells in vitro.  The fact that PGF2α at high concentration is able to activate the PGE2 receptor 
(Rao, 1974) could, in part, explain increases in progesterone production.  Additionally, the entire 
population of cells that would normally be present in addition to luteinized granulosal cells are 
not present in all in vitro experiments.  The inhibitory action of PGF2α on human luteinized 
granulosal cells may be enhanced by the presence of endothelial and/or immune cell types 
(Liptak et al., 2005).  
Structural and functional regression of corpora lutea  
Structural versus functional  
Through decades of luteal physiology research, luteal regression has come to be defined 
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as either structural or functional (Bowen-Shauver and Telleria, 2003).  Functional regression is 
defined as the cessation of P4 production, whereas structural regression refers to a decrease in 
weight and size of the CL (Goyeneche et al., 2002) and then disappearance of the structure on 
the ovary (Bowen-Shauver and Telleria, 2003).  Progress has been made in separating these two 
events in vivo, as well as distinguishing between the two in the literature.  However, it is 
important that these terms are defined in the context of both the species and the reproductive 
stage being studied (Davis and Rueda, 2002).   
Signs of functional regression occur prior to structural regression; presumably the loss of 
P4 production by the CL ultimately leads to its morphological changes and ultimately structural 
regression.  Initial changes seen in serum P4 are not due to loss of steroidogenic luteal cells, 
because numbers of large luteal cells do not decrease until after a dramatic decrease in P4 
(Braden et al., 1988).  Therefore, a decrease in blood flow to the CL and decreased steroidogenic 
capacity of luteal cells is one possible explanation for this decrease in P4.  However, a decrease 
in P4 prior to a decrease in luteal blood flow has been seen in rodents (Behrman et al., 1979) 
rabbits (Keyes et al., 1983) and domestic species (Ginther et al., 2007).  Studying spontaneous 
luteolysis has proven to be difficult because timing, duration and number of pulses of uterine 
PGF2α differ among individuals.  Decreased mRNA and protein of enzymes (3β-HSD, StAR, 
etc.) that contribute to luteal regression also are expressed at inconsistent times, which makes 
finding significant changes within a group of animals difficult due to the variation.  Due to this 
fact, researchers have focused on subsequent changes in these key factors after administration of 
PGF2α. 
Structural regression occurs due to a series of physiological changes that result in distinct 
morphological changes in the CL.  One such event that contributes greatly to the demise of the 
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CL is apoptosis, which is promoted by PGF2α (Sawyer, et al., 1990).  Apoptosis, also known as 
programmed cell death, is defined as an active, energy dependent process by which nonessential 
populations of cells are removed by other cells from tissue (Kerr et al., 1972), a mechanism that 
allows for control of cell numbers and tissue size.  Apoptosis in endocrine tissues commonly 
occurs after the tropic hormone is removed or a negative stimulus is activated.  Cells shrink, and 
fragments of both nuclear and cytoplasmic origin appear (Kerr et al., 1972).  Apoptosis is 
categorized into the intrinsic and extrinsic signaling cascade.  The intrinsic pathway is activated 
by apoptotic signals that originate within the cell in response to insults such as drugs, radiation, 
or growth factor withdrawal.  As a result, a change in mitochondrial permeability occurs through 
modifications in the ratio of pro- to anti-apoptotic Bcl-2 family members (Adams and Cory, 
1998).  Alternatively, the extrinsic pathway is activated by extracellular signals, such as Fas, or 
tumor necrosis factor alpha (TNF-α), that bind with cell surface receptors to inititate cell death 
(Nagata, 1997).  Caspases, a family of intracelluar proteases, are activated by both pathways and 
cleave multiple cellular components that contribute to the typical morphological appearance in 
apoptotic cells (Martin and Green, 1995).  These fragments, known as apoptotic bodies, are 
targets for macrophages and other immune cells.   
Specifically, the proportion of steroidogenic luteal cells in the CL of ewes decreased 
within 24 hours of PGF2α treatment during the maintenance phase (Braden et al., 1998).  Both the 
number and size of LLCs decreased, and this was followed by a decrease in the number of SLC 
(Braden et al., 1998).  Morphological changes in the steroidogenic cell population of the CL do 
not become visible until 24-36 hours post PGF2α (Sawyer et al., 1990), yet their ability to 
produce P4 has already been compromised.  This indicates that the structural changes in the CL 
are a consequence of reduced P4 production and not vice versa.  However, it could indicate that 
 15 
functional regression is regulated by a different mechanism than apoptosis, such as autophagy.   
Indeed, autophagy has been shown to play a role in structural regression in human and 
rats.  Autophagy is an intracellular bulk degradation system in which portions of cytoplasm are 
enveloped into autophagosomes that then undergo maturation and fusion with lysosomes for 
degradation (Klionsky and Emr, 2000).  The apperance of cytoplasmic vacuoles, prominent 
lysosomes, and the accumulation of lipfucsin pigment without any changes in nuclear 
morphology in the regressing primate CL strongly indicate that autophagy induces or at least 
plays a part in the death of steroidogenic luteal cells (Morales et al., 2000).  Additionally, 
autophagy has been shown to play a role in luteal regression in the rat by accumulation of 
autophagosomes, which then induce apoptotic cell death in luteal cells (Choi et al., 2011).  
Autophagy is promoted by adenosine monophosphate activated protein kinase (AMPK; Kim et 
al., 2011).  The role autophagy plays in bovine luteal regression has yet to be examined.  
However, AMPK reduced P4 production in murine, galline and bovine granulosal cells (Tosca et 
al., 2005; Tosca et al., 2006; Tosca et al., 2007), which will be discussed at greater length later in 
this review.  The link between AMPK and autophagy induction in bovine luteal tissue has not 
been determined.  
Factors involved in regression  
Luteal blood flow  
Changes in luteal blood flow have been proposed to be one of the main mechanisms by 
which PGF2α exerts its luteolytic actions (Nett et al., 1976; Knickerbocker, 1988).  In ewes, 
PGF2α reduces blood flow to the CL concomitantly with decreased secretion of P4 (Nett et al., 
1976). Color Doppler ultrasound is a non-invasive and useful technique to examine blood flow 
within the CL during its development (Acosta et al., 2003) and demise (Acosta et al., 2002).  On 
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days 16-18 of the estrous cycle in cattle, during spontaneous luteolysis, an increase in blood flow 
surrounding the CL was observed followed by decreased plasma P4 the next day (Shirasuna et 
al., 2004; Miyamoto et al., 2005).  An acute increase in blood flow (0.5 to 2 hours) also was seen 
during PGF2α-induced luteolysis in mature (day 10) but not developing (day 4) bovine CL 
(Acosta et al., 2002).  This increase was followed by a decrease in plasma P4 at 0.5 hours and 
blood flow at 8 hours (Acosta et al., 2002).  Expression of vasoactive factors must increase in 
order to mediate this increase in blood flow.  One such factor, nitric oxide (NO), a vasodilator, 
was proposed to be stimulated by PGF2α (Yamamoto et al., 2004).  Indeed, in a different tissue, it 
has been postulated that uterine PGF2α induces NO production from large arterioles to acutely 
increase luteal blood flow and initiate luteolysis (Miyamoto et al., 2005). However, other 
investigators were unable to find an increase in luteal blood flow at the initiation of luteolysis 
(Ginther et al., 2007).  In fact, a decrease in blood flow was not observed until the day after P4 
decreased (Ginther et al., 2007).  
Protective effect of progesterone  
Luteal P4 has been shown to exert protective effects on CL as a luteotropin by increasing 
the number of LH receptors in the early CL (Rothchild, 1981) and through anti-apoptotic activity 
(Rueda et al., 1997).  Direct supplementation of P4 to dispersed mature bovine luteal cells 
initiated a decrease in prostacyclin and PGF2α synthesis (Pate, 1988), which indicates that P4 
action could also be anti-luteolytic.  This evidence shows that P4 can protect the lifespan of the 
CL by blocking a decrease P4 production, reducing cell death, and preventing luteolytic factors 
such as PGF2α from regressing the CL.  The P4 receptor, PR, is present in LLC and some SLC, 
but not endothelial cells (Rueda et al., 2000), and it was further delineated that two isoforms of 
PR, PR-A and PR-B, are expressed in the bovine CL (Kotwica et al., 2004).  Protein synthesis of 
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these classical genomic receptors changes throughout the estrous cycle and pregnancy with the 
highest concentrations found at days 5-10 of the cycle and no expression in the regressing CL 
(Kotwica et al., 2004).  Actions of P4 could be exerted through the genomic receptor; however, 
these effects could be mediated by the glucocorticoid receptor (Sugino et al., 1997) or through 
the non-genomic plasma membrane bound PR (Peluso, 1997).   
Pulsatile uterine PGF2α  
Prostaglandin F2α is released in a series of pulses from the non-pregnant uterus in order 
to regress the bovine CL (Niswender, 2002).  Uterine release of PGF2α is transferred to the ovary 
through the utero-ovarian vein via a counter current exchange mechanism (McCracken et al., 
1972).  This helps ensure that PGF2α is not enzymatically inactivated in the lungs by PG 
dehydrogenase (PGHD) (Piper et al., 1970).  Transport of PGs through plasma membranes is 
poorly understand, but prostaglandin transporter (PGT) mediates the efflux and influx of PGF2α 
(Schuster, 1998).  Recently Lee et al. (2013) showed PGT protein was required for pulsatile 
release of PGF2α from the endometrium and to maintain a functional CL in sheep.  Number and 
frequency of pulses vary considerably during natural ruminant luteal regression but 
approximately 5 distinct pulses, each around 4-hour duration over a period of approximately 30 
hours, are required for luteal regression in heifers (Mann and Lamming, 2006).  In cattle, P4 
decreases during the ascending portion of a naturally occurring uterine PGF pulse but increases 
during the descending portion of the PGF pulse.  This is due to a pulse of LH stimulated by 
decreased P4, as well as loss of the negative effect of PGF.  A complete rebound in P4 occurs 
after each of a series of pulses of PGF2α before the first luteolytic pulse of PGF2α (Ginther and 
Beg, 2013) that causes a terminal decrease in P4. 
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Luteal endothelial cells  
Luteal endothelial cells contribute to luteal demise. Endothelial cells express PGF2α 
receptor (Mamluk et al., 1998), and administration of PGF2α caused degeneration of these cells 
(O’Shea et al., 1979) leading to reduced capillary density (Braden et al., 1988) and ultimately to 
decreased blood flow to the luteal parenchyma.  Endothelial cells appear to be one of the first 
cell types to be affected by PGF2α treatment by showing signs of apoptosis (Sawyer et al., 1990).  
Endothelial cells and more specifically the luteal endothelial cell product endothelial-I (ET-1), 
could mediate the luteolytic actions of PGF2α (Girsh et al., 1995).  Choudhary et al., 2005 
demonstrated that ET-1 increased concentration of intracellular Ca+2 in bovine luteal 
steroidogenic cells in vitro.  Additionally, SLC and LLC from mature (day-10) CL responded 
with a greater increase in Ca+2 than SLC and LLC of developing (day-4) CL (Choudhary et al., 
2002).  However, when different doses of ET-1 or PGF2α were administered to bovine luteal 
endothelial cells in vitro, no differences between the developing (day-4) and mature (day-10) CL 
were observed (Choudhary et al., 2005).  Basal and LH-stimulated P4 were reduced by ET-1 in 
the developing and mature bovine CL with similar responses (Choudhary et al., 2005).  The 
authors concluded that ET-1 is a tonic inhibitor of P4 secretion rather than a mediator of the 
action of PGF2α, and does not contribute to the insensitivity of the developing CL to luteolytic 
actions.   
Luteal immune response  
Immune cells such as macrophages, neutrophils, T cells, and eosinophils are present in 
both the developing and regressing CL.  In the bovine CL, markers of CD5+ or CD8+ T cells 
increased during stage IV (days 19-21) of the estrous cycle and from day 16 onward in natural 
luteal regression (Penny et al, 1999).  Similarly, markers of leukocytes, specifically macrophages 
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and T lymphocytes, significantly increased during luteal regression in cattle (Penny et al., 1999; 
Bauer et al., 2001).  During induced luteolysis of mature bovine CL, mRNA of TNF-α, 
interferon gamma (IFN-γ), and interleukin 1-beta (IL-1β) were all increased as soon as two hours 
after injection of PGF2α and continued to be elevated throughout 12 hours post PGF2α (Neuvians 
et al., 2004).  The wide range in time spanned by this influx of cytokines may indicate that they 
play roles in both functional and structural regression.  Up to 70% of proliferating cells in the 
regressing bovine CL are CD14+ macrophages (Bauer et al., 2001).  Recruitment of 
macrophages to the CL by the cytokine monocyte chemoattractant protein 1 (MCP-1) is 
enhanced by the ability of immune and endothelial cells to interact with one another (Shirasuna 
et al., 2012).  Penny (2000) proposed that on day 18 of the estrous cycle, PGF2α acts on various 
cell types in the CL, such as T-lymphocytes, endothelial cells, fibroblasts, and possibly immune 
cells directly, to induce MCP-1 production.  In the next 24 hours an influx of macrophages 
occurs in response to MCP-1, which is proposed to serve as an additional source of MCP-1 as 
well as playing an active role in structural regression (Penny, 2000).  Additionally, activated 
immune cells seem to produce a factor that impairs luteal cell P4 production because PGF2α 
enhances the production of luteal chemoattractant, and macrophages and eosinophils decrease P4 
secretion in the midphase CL in cattle (Pate, 1995).   
Signal Transduction Mechanism  
The mechanism governing the action of PGF2α is thought to involve activation of the 
phospholipase C-Ca2+ pathway (Davis et al., 1987).  The binding of PGF2α to its cognate Gq-
protein-coupled receptor causes dissociation of the α subunit from the β/γ subunit.  The α subunit 
exchanges GDP for GTP to activate phospholipase C (PLC; Davis et al., 1988).  Then, PLC 
cleaves plasma membrane-bound phosphatidylinositol 4,5-bisphosphate (PIP2) to generate free 
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IP3 (Berridge et al., 1983) and membrane-bound 1,2-diacylglycerol (DAG) (Berridge, 1987).  
Increase in both the concentration of cytoplasmic Ca2+ and activation of PKC are, in part, 
intracellular mediators of the actions of PGF2α in luteal cells (Wiltbank et al., 1990).  Even 
though it is generally referred to as PKC in signal transduction pathways, PKC is a family of 
protein kinases that can be divided into three subfamilies: classic (cPKC; α, βI, βII, and γ), novel 
(nPKC; δ, ε, η, and θ), and atypical (aPKC; ζ, ι, and λ) (Kang, 2014).  Sen et al. (2003) 
hypothesized that differential expression of PKC isozymes during the estrous cycle might 
explain inability of the developing CL to mount the same luteolytic response to PGF2α that is 
seen in the mature CL.  Indeed, both PKCε and PKCβII were expressed at higher concentrations 
in the mature CL (day 10) compared to the developing CL (day 4).  In both developing and 
mature CL, PGF2α had the capacity to activate conventional PKC isozymes.  Therefore the 
authors reasoned that these isozymes do not contribute to the insensitivity of developing CL to 
luteolytic actions of PGF2α (Sen et al., 2003).  Specific inhibitors of PKCε significantly 
decreased the PGF2α-induced rise in intracellular Ca+2  in LLC and SLC that in turn had 
consequences (at least in part) in the ability of PGF2α to inhibit LH-stimulated P4 secretion at 
this developmental stage (Sen et al., 2005).  Additionally, downregulating expression of PKCε 
reduced the ability of PGF2α to inhibit P4 synthesis/secretion (Goravanahally et al., 2007).   
In other studies, the next intracellular mediator, cytosolic Cat+2, was investigated.  
Developmental differences in the ability of PGF2α to induce increases in intracellular Ca+2 have 
been demonstrated in both LLC and SLC (Choudhary et al., 2005).  In vitro, PGF2α evoked a 
larger increase in intracellular Ca+2  in both SLC and LLC from mature (day-10) than developing 
(day-4) CL, and percentage of day-10 SLC responding increased as a function of PGF2α 
concentration (Choudhary et al., 2005).   
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Goravanahally et al., (2009) provided evidence that the luteolytic actions of increases in 
intracellular Ca2+ may be mediated through calmodulin dependent kinase kinase 2 beta 
(CAMKK2) because mRNA expression of CAMKK2 was upregulated in mature versus 
developing bovine CL.  Additionally, CAMKK2 gene expression was upregulated in mature 
bovine CL when PGF2α was administered in vivo 24 hours before CL removal (Goravanahally et 
al., 2009).  Whether CAMKK2 affects steroidogenesis directly or indirectly by acting upon 
another intermediary target is not known.  One such target is adenosine monophosphate activated 
protein kinase (AMPK; Wong, 2009) and it is a possible mediator for the luteolytic actions of 
PGF2α. 
PGF2α signal transduction pathway  
Adenosine monophosphate activated protein kinase (AMPK) 
Adenosine monophosphate activated protein kinase is an important regulatory protein for 
cellular energy balance in multiple cell types.  In all eukaryotic cells, AMPK is a heterotrimeric 
complex composed of one catalytic subunit α (with two isoforms: PRKAA1 and PRKAA2), and 
two regulatory subunits β (with two isoforms: PRKAB1 and PRKAB2) and γ (with three 
isoforms: PRKAG1, PRKAG2, and PRKG3) (Wong et al., 2009).  Different types of cells and 
tissues express distinctly different combinations of these subunits.  Activation of AMPK by 
phosphorylation of threonine 172 of the α subunit by upstream kinases, LKB1 or CAMKK2, is 
required for its activity (Wong et al., 2009).  A serine/threonine kinase, LKB1, is the primary 
upstream kinase of AMPK and appears to be constitutively active (Hardie, 2008).  When energy 
concentrations are depleted resulting in a decrease in ATP along with an increase in AMP, LKB1 
phosphorylates Thr 172. 
Specific tissues, such as neurons and endothelial-derived cells, express an alternate 
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pathway for activation of AMPK (Hardie, 2008).  Increases in cytoplasmic Ca+2 lead to 
activation of CAMKK2, which is capable of phosphorylating AMPK at Thr 172.  Free catalytic α 
subunits are usually inactive due to the presence of an autoinhibitory domain that is located in 
the center of the subunit.  Autoinhibition is eliminated when the α subunit forms a functional 
complex with the β and γ subunits.  The β subunit has key autoregulatory function in the AMPK 
complex, partially due to a specific sequence that binds to glycogen molecules (Guzman et al., 
2009).  A myristoylation site serves as a switch for reversible membrane binding of the complex, 
and a direct autoihibitory domain is located within the β subunit (Guzman et al., 2009).  The γ 
subunit is defined by the two Bateman domains, which selectively bind molecules that contain 
adenosine such as AMP or ATP (Bateman, 1997).  The binding of AMP to the γ subunit 
activates AMPK by inducing conformational changes in the complex that promote 
phosphorylation of Thr172.  Binding of ATP inhibits these changes.  Phosphorylation by AMPK 
of proteins that inhibit anabolic processes, such as those involved in metabolic pathways that 
reduce protein synthesis and cell proliferation and increase catabolic pathways that create energy 
such as glucose uptake, mitochondrial biogenesis, glycolysis and lipid oxidation (Hardie, 2008).  
Recently, activated AMPK has been shown to decrease P4 secretion in rat, cow, and primary F1 
hen granulosal cells (Tosca et al., 2005; Tosca et al., 2007; Tosca et al., 2006).  All subunits and 
their isoforms of AMPK have been characterized in bovine whole ovary, CL, small and large 
follicles as well as granulosal cells (Tosca et al., 2007).   
Pharmaceutical agents 
Thiazolinediones (TZDs) have been used as a form of medication for type II diabetes 
mellitus since the 1990’s.  This is the only approved use, TZD is being experimentally tested to 
treat polycystic ovarian syndrome (PCOS; Belfort et al., 2006), autism (Boris et al., 2007), and 
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ovarian hyperstimulation syndrome (Shah et al., 2010).  Peroxisome proliferator-activated 
receptors (PPAR), which are endogenously activated by free fatty acids and prostanoids, are also 
activated by TZDs.  Once activated, PPAR dimerizes with retinoid X receptor (RXR) to induce a 
specific cohort of gene expression.  In general, TZDs decrease triglycerides and increase high-
density lipoprotein cholesterol (HDL-C). 
Dorsomorphin dihydrochloride (DM), also known as Compound C, is a potent selective, 
cell-permeable and reversible AMPK inhibitor (Liu et al., 2014).  Dorsomorphin inhibited 
AMPK induced either by 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) 
(Tang et al., 2011) and metformin (Isakovic et al., 2007).  However, DM inhibited other kinases 
in addition to AMPK (Bain et al. 2007). 
One cell-permeable allosteric activator of AMPK is AICAR.  It is metabolized 
intracellularly to ZMP (5-aminoimidazole-4-carboxamide-1- β-D-ribofuranotide) by adenosine 
kinase (Merrill et al., 1997).  Phosphorylated AICAR, ZMP, is an AMP analog that interacts with 
the γ subunit of AMPK and induces kinase activation through allosteric changes in AMPK 
conformation (Merrill et al., 1997).  Although AICAR is used extensively in the laboratory, it is 
not ideal for clinical scenarios because of its short half-life, requirement for intravenous infusion, 
and variable effectiveness among patients (Wong et al., 2009).   
Metformin is another well-known activator of AMPK, although it activates the 
heterotrimeric complex indirectly.  Metformin is a biguanide that is developed from galegine, 
which is a derivative of the guanidine found in Galega officinalis (French lilac).  Metformin 
specifically works in the mitochondria by inhibiting the mitochondrial respiratory chain complex 
I.  Although the exact mechanism of action has yet to be elucidated, metformin inhibits complex 
I without affecting any other steps in the respiratory chain (Viollet et al., 2012).  Ultimately, 
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metformin reduces the synthesis of ATP by decreasing not only NADH oxidation but also proton 
pumping across the inner mitochondrial membrane and rate of oxygen consumption (Viollet et 
al., 2012).  This reduction in ATP results in a shift in the AMP: ATP ratio and causes the AMPK 
complex to become phosphorylated and therefore active (Viollet et al., 2012).   
Metformin is the most widely used drug for the treatment of type II diabetes, being 
prescribed to nearly 120 million people worldwide (Viollet et al., 2012).  It inhibits hepatic 
gluconeogenesis and augments the rate of glucose uptake in skeletal muscle (Bailey, 1996).  
Recently, metformin was used to treat women experiencing PCOS who were overweight or 
insulin resistant.  Metformin’s ability to increase insulin sensitivity in individuals made it an 
ideal candidate for the treatment of PCOS.  Metformin increased insulin sensitivity in patients 
with PCOS and it increased ovulation rate, improved menstrual cyclicity, and reduced serum 
androgen (Tang et al., 2010).  However, in 2007 Legro et al. showed that clomiphene citrate was 
superior to metformin in achieving live birth rates in infertile women with PCOS.  Metformin 
appears to work in PCOS patients by both direct ovarian effects and secondarily through 
decreasing insulin resistance.  In bovine granulosal cells isolated from small antral follicles 
steroidogenesis was affected by metformin treatment (Tosca et al., 2007).  Metformin (10 mM) 
reduced both P4 and E2 production as well as key enzymes (HSD3β, CYP11A1, and STAR), 
with or without FSH and/or IGF1 in the media (Tosca et al. 2007). 
Interestingly, metformin is a hydrophilic base that is excreted unchanged in the urine.  
Metformin cannot easily diffuse through cell membranes and is not metabolized into other 
variants when being eliminated from the body (Gruzman et al., 2009).  Metformin is a small 
molecule that has many transporters, known as organic cation transporters, in the kidney that 
lead to its high rate of renal clearance (Wong et al., 2009).   
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Model of activation of AMPK in the corpus luteum  
Changes in P4 biosynthesis due to activation of AMPK in the bovine CL stem from 
increases in intracellular Ca+2.  In addition to activating PKC, rises in Ca+2 activate calmodulin 
and therefore CAMKK.  The latter is responsible for phosphorylating AMPK and converting it to 
its active form that traditionally monitors the energy balance of the cell, but AMPK may not 
have this role in steroidogenic cells.  Typically, activation of AMPK results in a shift from 
anabolic processes, such as synthesis of proteins like enzymes involved in P4 production, to 
catabolic processes.  Additionally, AMPK activation leads to phosphorylation of fatty acid 
synthase (FAS), and acetyl-CoA-carboxylase (ACC1), key enzymes in de novo lipid synthesis.  
It may also regulate cholesterol uptake through lipoprotein receptors.  Progesterone is a steroid 
hormone and is derived from cholesterol that is made up of lipids.  This provides another 
mechanism to reduce overall P4 production (Figure 1.0). 
Statement of the problem 
The literature established that developmental differences exist in multiple facets of 
physiology between developing and mature bovine CL.  Changes in FP expression or PGF2α 
ligand, luteal blood flow, endothelial system, immune system, and the signal transduction 
mechanism have all been investigated in an attempt to explain the insensitivity of the developing 
CL to a luteolytic dose of PGF2α.  However, FP receptor expression is similar among developing 
and mature bovine CL, and, furthermore, PGF2α- mediated actions have been demonstrated at 
these two luteal developmental stages Therefore, a difference in the components of the signal 
transduction mechanim activated by PGF2α upon binding to its cognate FP exits between 
developing and mature CL.  In agreement with this idea, PGF2α elicited a difference in Ca+2 
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response between the two developmental stages of the bovine CL, and a down-stream target of 
Ca+2, CAMMK2, was differentially expressed in developing and mature CL.  CAMKK2 is 
known to phosphorylate AMPK, but this component of the signal transduction pathway has not 
been investiaged in relation to reproductive endocrinology.  Therefore, the goal of this project is 
to investigate alternative downstream components activated by the rise in cytosolic [Ca2+] 
initiated when the FP receptor is activated in both bovine luteal tissue and luteinized human 
granulosal cells.  The objectives of the research were: to determine the changes in P4 secretion in 
vitro and in vivo in the presence of an AMPK inhibitor or activator in developing and mature 
bovine CL; define changes in AMPK that occur as a result of FP activation; define changes in 
cholesterol transport that occur as a result of PGF2α binding to FP, which may be monitored by 
AMPK; define culture conditions and responses to luteotropic and luteolytic signals by luteinized 
human granulosal cells derived from patients with various infertility causes.  The proposed 
research has one central hypothesis: developmental differences in components of the signal 
transduction associated with FP expressed in developing and mature CL explain, at least in part, 





Figure 1.0:  Model of actions of AMPK in luteal cells.  Changes in progesterone biosynthesis due 
to activation of AMPK in the bovine CL stem from increases in intracellular Ca+2, calmodulin, 
and CAMKK2.  CAMKK2 phosphorylates AMPK and converting it to its active form results in a 
shift from anabolic processes to catabolic processes. Additionally, AMPK may regulate 
cholesterol uptake through lipoprotein receptors (LDLR and SRB-1).  This provides another 
mechanism to reduce overall progesterone production in addition to the established role of PKC.  
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Chapter 2: Effects of prostaglandin F 2 alpha and adenosine 
monophosphate activated kinase on progesterone production in the 
bovine corpus luteum in vivo  
 
Introduction  
The ability of bovine corpus luteum (CL) to respond to luteolytic actions of prostaglandin 
F 2 alpha (PGF2α) increases after ovulation in cattle.  Developing CL (days 1-5) fail to regress if 
a single exogenous bolus of PGF2α is given, yet administration of PGF2α at the same dose when 
the CL is at the mature stage (days 6-15) will induce regression with the cow returning to estrus 
within 48-72 hours (Rowson et al., 1972; Inskeep, 1973).  The cellular mechanisms responsible 
for this developmental difference are unclear. Lack of receptors (Wiltbank, 1995; Juengel et al., 
1998; Wright et al., 2014) or ability to elicit a physiological response to PGF2α (Tsai and 
Wiltbank, 1998; Choudhary et al., 2005; Sen et al., 2005) does not appear to explain the 
observed differences.  As discussed below, differences in the signal transduction mechanisms 
associated with FP receptor might explain some of the characteristics of the elicited response to 
PGF2α in mature versus developing CL.   
In luteal cells, PGF2α has affects by binding to its cognate Gq protein-coupled receptor 
and activating phospholipase C (PLC; Davis et al., 1988).  Then, PLC cleaves plasma 
membrane-bound phosphatidylinositol 4,5-bisphosphate (PIP2) to generate free IP3 (Berridge et 
al., 1983) and membrane-bound 1,2-diacylglycerol (DAG) (Berridge, 1987). Water-soluble IP3 
increases the concentration of cytoplasmic Ca2+, and DAG, which in combination with Ca2+, 
activates protein kinase C (PKC).  Increases in both cytoplasmic Ca2+ and activation of PKC 
have been demonstrated, in part, to mediate the actions of PGF2α in luteal cells (Wiltbank et al., 
1990).  Differential expression of genes encoding particular isoforms of PKCs and genes 
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participating in Ca2+ homeostasis have been implicated in acquisition of luteolytic capacity by 
the bovine CL.  In agreement with this suggestion, increased expression of two PKC inhibitors, 
histidine triad nucleotide binding protein (H1NT1) and tyrosine 2-monooxygenase\tryptophan 5-
monooxygenase activation protein zeta polypeptide (YWHAZ), appear to be involved in 
insensitivity of the early ovine CL (Juengel et al., 1998).  Indeed, YWHAZ gene expression was 
downregulated in mature bovine CL (Goravanahally et al., 2009).  Greater concentrations of 
PGF2α are needed to elicit Ca2+ responses in steroidogenic cells isolated from developing than 
from mature CL (Choudary et al., 2005).  Additionally, increased gene expression of CAMKK2, 
a down-stream target of Ca2+,  is more relevant in the activated signal transduction pathway in 
mature than in developing CL (Goravanahally et al., 2009). After an agonist-mediated rise in 
intracellular Ca2+ CAMKK2 was activated via phosphorylation by calcium/calmodulin-
dependent kinases (CAMKs) Whether CAMKK2 affects steroidogenesis directly or if it acts 
upon another intermediary step that impinges on steroidogenesis is not known.   
One intermediary step could be activated adenosine monophosphate activated kinase 
(AMPK), which is activated via phosphorylation by CAMKK2 (Wong, 2009).  Typically, 
activation of AMPK results in a shift from anabolic processes, such as protein synthesis or 
progesterone production, to catabolic processes. Activation of AMPK may regulate progesterone 
production by altering cholesterol uptake through high and low-density lipoprotein receptors 
such as scavenger receptor class B member 1 (SRB-1) and low-density lipoprotein receptor 
(LDLR).  Cholesterol influx is critical in steroidogenic cells because it is the preferred source 
over de novo synthesis in this tissue.  Both LDL and HDL provide substrate for progesterone 
production.  During luteal regression in primates, gene expression for lipoprotein receptors SRB-
1 and LDLR decreased (Bogan et al., 2009, 2010).  Downregulation of LDLR activity in human 
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fibroblast cells increased expression of acyl CoA cholesterol acyltransferase (ACAT) (Brown et 
al., 1975), which is responsible for esterification of free cholesterol.  These cholesterol esters are 
stored in lipid droplets and are hormonally regulated in steroidogenic cells of the adrenal, ovary 
and testis (Behrman and Greep, 1972; Hou et al., 2010).  The possibility that PGF2α predicates 
luteolytic actions of AMPK regulation changes in cholesterol transport has yet to be explored in 
the bovine CL. 
One well known activator of AMPK is metformin, which is the most widely used 
pharmaceutical for treatment of type II diabetes being prescribed to nearly 120 million people 
worldwide (Viollet et al., 2012).  Metformin activates AMPK by reducing synthesis of ATP 
through NADH oxidation, which results in a shift in AMP: ATP ratio and phosphorylation of the 
AMPK complex (Viollet et al., 2012).  In addition, metformin has been used to treat polycystic 
ovary syndrome (PCOS) in women who were overweight or insulin resistant.  Metformin 
directly affects the ovaries and also decreases insulin resistance in PCOS patients.  Additionally, 
metformin has been shown to reduce progesterone and estradiol production in bovine granulosal 
cells isolated from small antral follicles (Tosca et al., 2007).  Reduced steroidogenesis resulting 
from metformin treatment indicates a potential role in progesterone production in the bovine 
ovary.    
Therefore, the objective of this study was to investigate if AMPK played a role in the 
signal transduction pathway used by FP receptors in mature bovine CL.  The specific aims of this 
research were to determine changes in progesterone secretion in vivo in response to activation of 
AMPK via metformin in mature bovine CL; define changes in protein expression of AMPK, 
phosphorylated AMPK (P-AMPK) and steroidogenic acute regulatory (StAR) resulting from FP 
activation, and characterize cholesterol transport proteins (LDL, SRB-1, ACAT-1) during 
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functional regression after activating FP via exogenous PGF2α.  The overall hypothesis is that 
luteal developmental differences in signal transduction associated with FP can explain, at least in 
part, the differences in the ability of PGF2α to induce functional luteal regression in the mature 
but not the developing bovine CL. 
Materials and Methods 
Non-lactating beef cows were observed twice daily for estrus at approximately 12 h intervals for 
30 min per observation.  The day when standing estrus was observed was designated as day 0 
(d0).  The West Virginia University Animal Care and Use Committee reviewed and approved 
the protocol for the tissue collection (ACUC # 01-0809). 
Experiment 1 
Cows (450-700 kg BW) were assigned randomly among treatment groups: day 10 hour 0 
(d10-h0; n = 5), day 10 hour 2 (d10-h2; n = 5), day 10 hour 4 (d10-h4; n = 5).  Cows received a 
subcutaneous injection of PGF2α (25 mg, Lutalyse®; Zoetis Florham Park, NJ) or saline (d10-h0) 
0, 2, or 4 hours prior to lutectomy.  Corpora lutea (CL) were collected via supravaginal incision 
under epidural anesthesia (Casida, 1959) with administration of 6-9 mL of 2% lidocaine (Butler 
Company, Columbus, OH).  CL were weighed and divided into equal sections for protein 
isolation and measurement of luteal progesterone.  Tissue for protein isolation was snap frozen in 
liquid nitrogen and stored at -80°C; remaining tissue was transported to the laboratory in ice-cold 
saline.  Tissue for luteal P4was homogenized with an Omni Tissue Homogenizer (Omni 
International, Kennesaw, GA) and then frozen at -20°C until assayed for P4via RIA.  Blood 
samples were collected hourly via caudal venipuncture until CL excision.  Samples were allowed 
to clot and then centrifuged at 3500 x g for 15 minutes, and serum was collected and stored at -
20°C.  Serum and CL assayed by RIA for P4 as previously described (Sheffel et al., 1982).   
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Luteal proteins were analyzed using semiquantitative Western blotting as previously 
described (Sen, 2004).  Briefly, protein was isolated from d10-h0, d10-h2 and d10-h4 CL by 
homogenizing the luteal tissue in a buffer containing 50 mM Tris HCl, 150 mM NaCl, 1 mM 
EGTA, 1 mM EDTA, 0.1% SDS, 1% Triton-X, protease inhibitors (2 mM 
phenylmethylsulfonylfluoride, 5 μg/μl leupeptin, 5 μg/μl aprotinin), and phosphatase inhibitors 
(100 mM sodium fluoride, 2 mM sodium orthovanadate, 10 mM sodium pyrophosphate). Sample 
protein concentration was determined using a Bio-Rad (Hercules, CA) assay with bovine serum 
albumin (BSA; Gibco BRL) as a standard.  After concentrations were determined, 100 μg/lane of 
protein was loaded for StAR, AMPK, P-AMPK, SRB-1, and LDLR. Proteins were resolved with 
a 4-15% gradient polyacrylamide TGX gel (Bio-Rad, Hercules, CA) and transferred to 
polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA) using a Bio-Rad Mini 
Trans-Blot Cell (Hercules, CA).   
Primary antibodies used included 1) StAR antibody (#bs-3670R, Bioss, Boston, MA) at 
1:250 (v/v) 2) AMPK antibody (#2532S, Cell Signaling Technology, Danvers, MA) 1:1000 (v/v) 
3) P-AMPK antibody (#2537S, Cell Signaling Technology, Danvers, MA) 1:1000 (v/v) 4) LDL-
R antibody (LS-C146979, LSBio, Seattle, WA) 1:500 (v/v) 5) SRB-1 antibody (#ab24603, 
AbCam, Cambridge, MA) (1:1000) 6) and beta actin (A2228; Sigma-Aldrich, St. Louis, MO) at 
a dilution of 1:2000 (v/v) and incubated overnight at 4°C with gentle shaking. Secondary 
antibodies included goat anti-mouse IRDye 680RD (for actin) diluted to 1:10 000 and goat anti-
rabbit IRDye 800CW (for StAR, AMPK, P-AMPK, LDL-R, SRB-1) diluted to 1:10 000 (v/v) 
(#926-68170, #827-08365, Li-Cor, Lincoln, NE).  A two-color detection scheme was used to 
permit simultaneous probing for target proteins.  Band intensity imaging was captured using 
Odyssey infrared imaging software and quantified through densitometry (ImageJ Bethesda, 
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Maryland).  Signal intensity for a protein of interest was standardized to the corresponding 
intensity of actin in the same sample. This normalization procedure for semiquantitative 
estimation of protein was validated by Sen et al. (2004). 
Materials and Methods 
Non-lactating beef cows were observed twice daily for estrus at approximately 12 h intervals for 
30 min per observation.  The day of standing estrus was designated as day 0 (d0).  The West 
Virginia University Animal Care and Use Committee reviewed and approved the protocol for the 
tissue collection (ACUC # 12-1008).   
Experiment 2 
Cows were assigned randomly to treatment groups, which received 15 (Met-15, n = 4) or 
30 (Met-30, n = 4) mg/kg of BW of metformin (New England Mail Order Pharmacy, 
Middlebury, VT) every 3 hours for 12 hours on d10 of the estrous cycle.  Metformin was 
pulverized and dissolved into sterile saline solution before centrifugation at 119 RCF for 5 
minutes to remove non-active binding ingredients.  Supernatant was collected for infusion, the 
pellet was washed; and the supernatant was collected and added to the total infusion volume.  An 
artificial insemination catheter was passed through the cervix, and metformin was deposited into 
the uterus by a syringe connected to the catheter by a 200 μl pipette tip.  Based on observations 
from this study, a dose of 30 mg/kg BW of metformin (metformin, n = 7) or saline (control, 
 n = 7) was injected into the jugular vein of cows (n = 7) every 3h for 12 hours.  Blood samples 
were collected one day prior to and hourly for 12h after the first metformin infusion and then one 
and two days after treatment. Blood samples were allowed to clot, and then centrifuged at 3500 x 
g for 15 min.  Serum was collected and stored at -20°C until assayed by RIA for P4 (Sheffel et 
al., 1982) and for metformin (Amini et al., 2005).  Serum concentrations of insulin were 
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determined by RIA kit (Insulin Coat-A-Count; Diagnostics Products Corporation; Los Angeles, 
CA).   Signs of estrus were monitored daily for 2 weeks after treatment.   
Statistical Analysis 
Normalized protein concentrations ratios were tested for normal distribution via the 
Shapiro-Wilk test (Shapiro and Wilk, 1965). A one-tailed Student’s t-test was used for 
comparison of data sets that had a normal distribution. For data sets that did not have a normal 
distribution, a one-tailed Wilcoxon two-group test (Mann-Whitney test) was used.  
Concentrations of serum P4 was examined using ANOVA with repeated measures, and serum 
concentrations of insulin, as well as luteal P4 content, was examined using ANOVA with 
Dunnett’s Method post hoc test.  Data were analyzed using JMP and SAS software (JMP®, 
Version Pro 11, SAS Institute Inc., Cary, NC, Copyright ©2013; SAS®, Version 9.3, SAS 
Institute Inc., Cary, NC, Copyright ©2002-2010). Significance criterion alpha for all tests was 
0.05.  Data are depicted as the mean ± SEM.  
Results 
Experiment 1  
A decrease in serum P4concentration and luteal P4content at 2 h (2.08 ng/ml vs. 2.96 
ng/ml; P = 0.054) and 4 h (1.57 ng/ml vs. 2.96 ng/ml; P = 0.013) was observed after PGF2α 
administration (d10-h0 = 5.05 ng/ml; d10-h2 = 2.03 ng/ml; d10-h4 = 1.74 ng/ml) (Figure 1.1).  
Changes in protein expression of LDL, SRB-1, AMPK, StAR, and ACAT-1 are shown in Figure 
1.2.  There was no detection of P-AMPK.  A decrease in LDL protein expression was observed 
at 2 h (0.79 vs. 0.41; P = 0.09) and at 4 h after PGF2α injection (0.79 vs. 0.13; P = 0.004) (Figure 
1.2-A).  An increase in ACAT-1 occurred by 4 h (0.67 vs. 0.21, P = 0.010) after PGF injection 
(Figure 1.2-B).  There was a significant quadratic effect of treatment and time (P = 0.037) for 
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AMPK protein expression (Figure 1.2-C).  An increase in StAR protein expression was observed 
4 h (3.62 vs. 1.25, P = 0.01) after PGF2α injection, but not at 2h (1.02 vs. 1.74, Figure 1.2-D).  
There was also a quadratic effect of treatment and time (P = 0.05) for StAR protein expression, 
with H4 having the highest ratio (Figure 1.2-D).  No difference in SRB-1 protein expression 
occurred at either 2 (1.92 vs. 1.74) or 4 h (2.75 vs. 1.74) after PGF injection (Figure 1.2-E). 
Experiment 2 
The preliminary experiment revealed that even though concentrations of metformin were 
detectable in blood after intrauterine administration, which is shown by the representative HPLC 
metformin determination from a 30-mg/kg bw cow in Figure 1.3; intravenous administration was 
simpler.  There was a decrease in serum concentrations of P4 (P = 0.001) with 30 mg (1.01 ± 
0.08 ng/ml) of metformin compared to 15 mg (1.33 ± 0.08 ng/ml, Figure 1.3).  However, days to 
estrus was not different between the groups (x = 21 d ± 1).  Figure 1.4 illustrates that in the there 
was no difference in P4 between metformin (0.784 ± 0.15 ng/ml) and saline (0.788 ± 0.29 
ng/ml).  Additionally, there was no difference in insulin concentrations between saline (4.49 ± 
0.154 µg/L) and metformin (4.48 ± 0.154 µg/L) treatments (P > 0.05; Figure 1.5), or time to 
return to estrus (x = 11 d ± 1). 
Discussion 
These results corroborate that activation of the FP receptor by exogenous PGF2α causes a 
decrease in serum and luteal P4 concentrations (Juengel et al., 1993; Wiltbank et al., 1995; Tsai 
and Wiltbank 1998; Atli et al., 2012).  Similarly, both serum concentrations and luteal P4 content 
decreased by 4 hours after PGF2α administration.  These decreases of both serum and luteal P4 
were observed as early as 2 h after PGF2α, yet no changes in serum P4 were observed at 1 h after 
PGF2α (data not shown).  These data established a time frame for the process of functional 
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regression after exogenous injection of PGF2α. 
During this functional regression, cholesterol transport through LDLR was lower at 2 and 
4 h after PGF2α, indicating that substrate transport by these receptors was critical during 
reduction of P4 production.  Lower LDLR would lead to decreased cholesterol, the substrate for 
P4 production.  Decreases in LDL receptors reduce 3-hydroxy-3-methylglutaryl coenzyme A 
reductase (HMG-CoA reductase), catalyzing a rate-limiting step in cholesterol production 
(Siperstein, 1970), and increasing ACAT-1 (Brown et al., 1975).  Cells adjust to the number of 
LDL receptors in order to produce sufficient cholesterol for the metabolic need of the cell 
without over accumulation (Brown and Goldstein, 1975).  This function is key because cells are 
able to keep the concentration of unesterified cholesterol in membranes constant, while 
requirements and exogenous supply are fluctuating constantly (Goldstein and Brown, 2009).  
The observed increases of ACAT-1 indicate an attempt by the luteal tissue to compensate for 
decreases in cholesterol.   
No change in SRB-1 in mature CL was observed after PGF2α administration.  During 
spontaneous luteolysis in primate CL, changes in gene expression or protein concentrations of 
SRB-1 were not different between mid-late to functional late CL but were decreased from 
functional to functionally regressed late stage CL (Bogan et al., 2009, 2010).  Functional late CL 
were defined as having been collected on day 14-16 of the menstrual cycle, and functionally 
regressed late CL were a subset of those CL from animals with serum P4values less than 0.5 
ng/ml (Bogan et al., 2009).  Based on the criteria used by Bogan et al. (2009, 2010), the time 
points used in the current study after PGF2α was given, could have reflected functional 
regression; whereas, the results reported by Bogan et al. reflected structural regression. 
 Expression of AMPK mRNA has been measured in whole bovine ovaries, small and 
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large follicles, oocytes, and CL.  Additionally, AMPK-α subunit protein expression was detected 
in small and large follicles and their granulosal cells (Tosca et al., 2007).  Previous data indicated 
a developmental difference in AMPK gene expression between developing and mature CL, with 
increased expression in mature bovine CL (Goravanhally, unpublished results).  Therefore 
activation of AMPK would have a greater effect in the mature than developing CL.  Activation 
of AMPK using metformin decreased P4 production in bovine granulosal (Tosca et al., 2007) 
and luteal cells (Hou et al., 2009). Thus, elevated concentrations of AMPK protein observed 2 h 
after FP activation may serve as a mechanism by which both serum and luteal P4concentrations 
are decreased.  At 4 h after FP activation, P4 concentrations decreased such that AMPK 
activation was not required to mediate further decreases in steroid production.  No detection of 
P-AMPK occurred at either 2 or 4 hours.   This may be a result of rapid AMPK phosphorylation. 
Park et al. (2002) reported AMPK phosphorylation within 5 seconds in skeletal muscle of rats.  
Therefore, time points chosen after PGF2α may have been too late to observe any change in  
P-AMPK.   
 Metformin was delivered successfully into the uterine lumen of the cows, and detection 
of its presence in serum was achieved using HPLC.  This delivery method was chosen originally 
due to the concept that counter-current exchange in the utero-ovarian vein (McCracken et al., 
1999) would aid in delivery of metformin to the CL.  Despite the fact that metformin was 
detectable in blood, passing the AI rod through a cow in the luteal phase was technically 
difficult.  Differences in P4 concentration were observed between 15 and 30 (mg/kg of BW) 
doses of metformin during the preliminary study.  The 30 mg dose was chosen based on studies 
in horses, in which metformin was being used as treatment for insulin resistance (Hustace et al., 
2009; Rendle et al., 2013).  This observation combined with the lack of visible negative side 
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effects of metformin on cows, indicated that a 30 mg/kg of BW dose would be appropriate for IV 
administration in subsequent experiments.  However, at this dose there was no difference in P4 
concentrations between the metformin- and saline-treated cows, and no difference in their time to 
return to estrus.  Additionally, no changes in insulin concentrations after metformin were 
observed.  This was surprising because this same dose caused a significant decrease in insulin 
concentrations in horses (Rendle et al., 2013).  A greater dose of metformin might have elicited a 
response in both insulin and P4 production.  This would be difficult to test due to the cost 
prohibitive nature of administering a drug that is used in the human market to treat patients with 
PCOS (Tang et al., 2010) and diabetes (Viollet et al, 2012). 
 In summary, activation of the FP receptor caused a decrease in luteal and serum 
P4concentrations as soon as two hours after exogenous administration PGF2α.  Alterations in 
cholesterol transport accounted for this reduction, at least in part, in P4production.  Changes in 
AMPK protein during this same time period indicate that it may be the downstream target of FP 









Luteal progesterone (ng/ml) = 4.498 - 0.7984*Time from PGF2α (Hour) 
 
 
Figure 1.1: Bivariate fit of serum (A) and luteal (B) P4 (ng/ml) by time from PGF2α  (hour).  
Significant declines in serum and luteal progesterone occurred at both 2 and 4 hours after PGF2α.    
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Figure 1.2: Semiquantitative analysis of the densitometric data derived from Western blots using 
protein samples isolated mature bovine CL 0, 2, and 4 hours after PGF2α.  The y-axis shows the 
ratio of the optical density (o.d.) for the protein of interest corrected by the detected o.d. for its 
corresponding actin. The data are given as mean ± SEM; values with differing letters denote 



























































































































Figure 1.3:  A-Serum progesterone values for 15 or 30 (mg/kg of bw) IU of metformin.  Serum 
progesterone was significantly lower 12 hours after starting treatment (P < 0.001) when cows 
received 30 mg/kg bw than when cows received 15 mg/kg bw.  B-Representative HPLC graph of 
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Figure 1.4: Serum progesterone concentrations pooled across all experiments showed that there 






































Figure 1.5: Serum insulin concentrations one day prior to and during metformin treatment.  Cows 
were given 30 mg/kg bw of metformin IV or sterile saline for control cows every 3 hours over 12 
hours, during the day of treatment.  No significant difference of treatment or time was seen in 














































Chapter 3: Adenosine monophosphate activated protein kinase activation in 




The mechanisms governing the action of prostaglandin F 2 alpha (PGF2α), are 
incompletely known.  Nevertheless, this mechanism involves activation of the phospholipase C-
Ca2+ pathway (Davis et al., 1987).  In luteal cells, PGF2α has affects by binding to its cognate Gq 
protein-coupled receptor and activating phospholipase C (PLC; Davis et al., 1988).  The PLC 
cleaves plasma membrane-bound phosphatidylinositol 4,5-bisphosphate (PIP2) to generate free 
IP3 (Berridge et al., 1983) and membrane-bound 1,2-diacylglycerol (DAG; Berridge, 1987), 
which increases Ca2+ and activates protein kinase C (PKC), respectively.  Increases in both 
concentrations of cytoplasmic Ca2+ and activation of PKC have been demonstrated to mediate 
intracellular actions of PGF2α in luteal cells (Wiltbank et al., 1990).  Differential expression of 
genes associated with Ca2+ homeostasis plays a role in the development of luteolytic capacity of 
bovine CL.  Greater concentrations of PGF2α are needed to elicit Ca2+ responses in steroidogenic 
cells isolated from developing than from mature CL (Choudary et al., 2005).  Additionally, gene 
expression of CAMKK2, a down-stream target of Ca2+, is increased in mature CL 
(Goravanahally et al., 2009).  The serine/threonine protein kinase CAMKK2 has been reported to 
mediate the action of intracellular Ca2+ via phosphorylation of calcium/calmodulin-dependent 
kinases (CAMKs).  Whether CAMKK2 affects steroidogenesis or rather acts upon another 
intermediary to mediate its effects is not known.  One target of CAMKK2 is adenosine 
monophosphate activated protein kinase AMPK (Wong, 2009).  The kinase CAMKK2 
phosphorylates AMPK, but this particular component of this signal transduction pathway has not 
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been investigated in the bovine CL.   
In multiple cell types, AMPK is an important regulatory protein for energy balance.  In 
all eukaryotic cells it is a heterotrimeric complex composed of one catalytic subunit α (with two 
isoforms: PRKAA1 and PRKAA2) and two regulatory subunits β (with two isoforms: PRKAB1 
and PRKAB2) and γ (with three isoforms: PRKAG1, PRKAG2, and PRKG3; Wong et al., 
2009).  Increases in cytoplasmic Ca+2 lead to activation of CAMKK2, which is capable of 
phosphorylating AMPK at Thr 172.  Binding of AMP to the γ subunit activates AMPK by 
inducing conformational changes in the complex that promote phosphorylation of Thr172.  
Typically, activation of AMPK results in a shift from anabolic processes (Hardie, 2008), such as 
synthesis of proteins that are required for progesterone (P4) production, to catabolic processes.  
Recently, activated AMPK decreased P4 secretion in murine, bovine, and primary F1 galline 
granulosal cells (Tosca et al., 2005; Tosca et al., 2006; Tosca et al., 2007).  All subunits of 
AMPK and their isoforms were present in whole ovaries, CL, small and large follicles as well as 
granulosal cells in the cow (Tosca et al., 2007).  AMPK is activated in response to the 
antidiabetic drug metformin (Viollet et al., 2012), and by 5-Aminoimidazole-4-carboxamide-1-β-
4-ribofuranoside (AICAR), a cell-permeable allosteric AMPK activator (Corton et al., 1995).  
Dorsomorphin dihydrochloride (DM) is a potent, selective, cell-permeable and reversible AMPK 
inhibitor (Liu et al., 2014).  It inhibited AMPK induced either by AICAR (Tang et al., 2011) or 
metformin (Isakovic et al., 2007).  If CAMKK2 targets AMPK in bovine CL, increased gene 
expression of CAMKK2 during this developmental stage may lead to increased AMPK 
activation, and, therefore, become an additional mechanism to mediate effects of PGF2α.  
The goal of this project was to investigate alternative downstream components activated 
by the rise in cytosolic [Ca2+] initiated when the FP receptor is activated in bovine luteal tissue.  
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The objectives of this research were to determine the changes in P4 secretion in the presence of 
AMPK activators or inhibitor in developing and mature bovine CL in vitro.  Developmental 
differences in components of signal transduction associated with AMPK activation in developing 
and mature CL may explain, at least in part, the developmental differences in the ability of 
PGF2α to induce functional luteal regression. 
Materials and Methods 
Animal Handling and Surgical Procedures 
Non-lactating beef cows were observed twice daily for estrus at approximately 12 h intervals for 
30 min per observation.  The day when standing estrus was observed was designated as day 0 
(d0).  The West Virginia University Animal Care and Use Committee reviewed and approved the 
protocol for the tissue collection (ACUC # 01-0809).Ovaries (d4; n = 5) or CL (d10; n = 5) were 
collected via supravaginal incision under epidural anesthesia (Casida, 1959) and transported in 
ice-cold saline to the laboratory.  Connective tissue was removed prior to obtaining weights and 
slicing for treatment.   
Luteal Slice Incubation Procedure  
Luteal slices were incubated for 30 min with 500 µl of minimum essential media (MEM, Life 
Technologies, Grand Island, NY) and pharmaceutical agents before hormones were added.  
Media were removed, and fresh media added back along with treatments for 2 hr incubation at 
37°C, shaking at 200 rpm.  Progesterone was assayed by radioimmunoassay (RIA) as previously 
described (Sheffel et al., 1982). 
Experiment 1 
Luteal slices were treated with MEM (control), PGF2α (1.0 μg/ml), DM (10.9 µM/L, Tocris, 
Bristol, UK), or DM (10.9 µM/L) and PGF2α (1.0 μg/ml).  Media were collected and frozen at -
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20°C until assayed for P4.   
Experiment 2 
Luteal slices were treated with MEM (control), PGF2α (PGF2α, 1.0 μg/ml), metformin (Met; 10, 
5, 1, 0.5, 0.1 mM; New England Mail Order Pharmacy, Middlebury, VT), or AICAR (7.5, 0.75, 
0.075 mM, Tocris, Bristol, UK).  After incubation, slices were homogenized using an Omni 
Tissue Homogenizer (Omni International, Kennesaw, GA) in incubation media and frozen at -
20°C until assayed for P4.   
Statistical Analysis  
Progesterone values were analyzed using ANOVA followed by Dunnett’s Method for means 
comparisons to control. T-Test was used to compare the value of progesterone at the highest dose 
of metformin and AICAR with control values in both D4 and D10.  Data were analyzed using 
JMP and SAS software (JMP®, Version Pro 11, SAS Institute Inc., Cary, NC, Copyright ©2013; 
SAS®, Version 9.3, SAS Institute Inc., Cary, NC, Copyright ©2002-2010). Significance 
criterion alpha for all tests was 0.05.  Data are depicted as the mean ± SEM. 
Results 
Experiment 1 
No significant effects of PGF2α (0.94 ± 0.13; P = 0.96), DM (1.921 ± 1.3, P = 0.39), or PGF2α 
and DM (1.11 ± 0.53; P = 0.91) were observed on P4 production when compared to basal values 
(1.00 ± 0) in d4 CL.  In d10 CL, PGF2α increased P4 production (2.4 ± 0.35 vs 1.00 ± 0; P = 
0.0003), while DM treatment alone (1.34 ± 0.11 vs. 1.00 ± 0) had no effect (P = 0.24).  
Stimulatory effect of PGF2α was eliminated when DM was added, such that P4 values did not 
differ from controls (1.85 ± 0.54 vs 1.00 ± 0; P = 0.31) but were different from PGF2α alone 




No significant effect of metformin (P = 0.91) or AICAR (P = 0.51) at any concentration was 
observed in D4 CL.  A decrease in basal P4 was observed with both metformin (0.39 ± 0.20; 10 
mM; P = 0.006) and AICAR (0.40 ± 0.15; 7.5 mM; P = 0.0117) in D10 CL when compared to 
control (0.99 ± 0.32). 
Discussion 
These results indicate that AMPK is involved in the signal transduction mechanism of the 
mature but not developing bovine CL.  No significant changes were observed in P4 production 
when d4 luteal tissue was treated with DM, metformin, or AICAR.  However, d10 CL responded 
to all AMPK activators with a significant inhibition in P4 production, and the AMPK inhibitor 
eliminated this effect.  All subunits of AMPK are present in the bovine ovary (Tosca et al., 
2007), but gene expression of these subunits might change throughout development of the CL.  
In fact, Goravanahally (unpublished results) demonstrated that, with the exception of AMPKγ1 
and AMPKγ2, mRNA expression of AMPK subunits were increased in the mature CL  
(P < 0.05).  Moreover, an additional observation supporting the interpretation that the effects of 
increases in cytosolic calcium are conveyed via CAMKK2-AMPK was that a CAMKK2 
inhibitor, STO-609, blocked the inhibitory effects of PGF2α in dispersed mature bovine luteal 
cells (Goravanahally, unpublished results).  STO-609 also inhibited PGF2α-induced 
phosphorylated state of AMPK (P-AMPK) in mature but not developing bovine CL.  
Collectively, these data demonstrate that the signal transduction pathway involving CAMKK2 
and AMPK regulates luteal function in the mature, but not the developing CL. 
 Tosca et al. (2005, 2006, 2007) have provided evidence in the rat, hen, and cow that 
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AMPK is involved in steroid production in granulosal cells.  It is not surprising that AMPK plays 
a role in steroidogenesis of luteal cells, as this population is derived from granulosal cells.  In 
agreement with previous results, these data reveal that metformin and AICAR decreased basal P4 
production.  The effects of DM were developmentally different; DM had no effect on P4 
production in developing CL, but blocked the stimulatory effects of PGF2α in mature CL.  
However, lower doses of metformin (5, 1, 0.5, 0.1 mM) or AICAR (0.75, 0.075 mM) did not 
affect P4 production.  Doses of both AMPK activators were based on previous reports, in which 
a significant decline in basal P4 production was seen in vitro (Tosca et al., 2005; Tosca et al., 
2007).  However, CL tissue from this study was incubated for 2 hours before collection, 
compared to the range of 3 to 48 hours in the previous study with bovine granulosal cells (Tosca 
et al., 2007).  Differences in P4 were significant at 2 hours of incubation, but longer incubation 
times with lower doses may have decreased steroid production.   
 In conclusion, DM eliminated the effect of PGF2α on mature but not developing bovine 
CL.  Higher doses of metformin and AICAR were capable of decreasing P4 in mature but not in 
developing bovine CL.  This developmental difference in signal transduction may play a 










Figure 2.1-DM reduced the stimulatory effect of PGF2α on P4 secretion in mature (D10) but 
neither PGF2α nor DM alone or in combination with PGF2α or LH were affected in the developing 
CL (D4).  Luteal slices were incubated for 30 minutes in MEM and DM without hormones after 
which all media were removed, and fresh MEM, DM and hormones were added back.  Media 
were collected and frozen until analyzed for progesterone with RIA.  Different letters indicate 
























































































Figure 2.2: Neither PGF2α nor its activators, metformin and AICAR, had any significant effect on 
basal progesterone production in developing (D4) bovine CL. Luteal slices were incubated for 30 
minutes in MEM and metformin or AICAR without hormones after which all media were 
removed, and fresh MEM, metformin or AICAR and hormones were added back.  Slices were 
homogenized in the media and then collected and frozen until analyzed for progesterone with 




































































Figure 2.3: At the greatest concentrations tested, both metformin and AICAR significantly (P < 
0.05) decreased basal progesterone production in mature (D10) bovine CL.  Luteal slices were 
incubated for 30 minutes in MEM and metformin or AICAR without hormones after which all 
media were removed, and fresh MEM, metformin or AICAR and hormones were added back.  
Slices were homogenized in the media and then collected and frozen until analyzed for 






















































Chapter 4: Primary infertility affects progesterone production by 
luteinized human mural granulosal cells in vitro  
 
Introduction  
Follicles, comprised of the oocyte, granulosal and thecal cells, are the functional unit of 
the ovary.  The somatic cells in the outermost vascular portion of the follicle include thecal and 
myoepithelial cells.  The avascular component of the follicle is delimited by a basement 
membrane upon which the other somatic cells of the follicle, the granulosal epithelial layer and 
the germ cell reside.  Two populations of granulosal cells have been identified: mural and 
cumulus granulosal cells.  Both populations of cells are organized as a stratified epithelium with 
the basal layer of mural cells contacting the basement membrane adjacent to the thecal cells and 
the cumulus cells surrounding the oocyte (Buccione et al., 1990).  Mural granulosal cells express 
receptors for FSH and LH as well as the enzymes 3β-HSD and P450scc (Zoller and Weisz, 
1979).  Expression of these two enzymes is representative of a luteal characteristic in these cells, 
while cumulus granulosal cells remain with the oocyte even after ovulation (Russell and Salustri, 
2006).  Once ovulation has occurred, mural granulosal cells lose their ability to proliferate, 
undergo epithelial-mesenchymal transition and differentiate into large luteal cells (LLC) of the 
corpus luteum (CL), which secrete high amounts of basal progesterone (P4; Chaffkin et al., 
1992).  Interestingly, P4 receptors (PGR) cannot be detected with immunohistochemical analysis 
in human granulosal cells at any follicular stage but they are detected readily in human luteal 
tissue (Suzuki et al., 1994).  The fact that PGR is absent in preovulatory follicles but present in 
periovulatory follicles and in the CL after a surge of gonadotropins supports the hypothesis that 
LH induces PGR expression (Hild-Petito et al., 1988).  Thecal cells become small luteal cells 
(SLC) once luteinization has occurred.   
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In the CL of primates, granulosal and thecal cells remain as two distinct populations and 
are separated by the remnants of the follicular basement membrane (Guraya, 1971).  In contrast, 
the basement membrane separating these two cell populations is remodeled, and thecal cells, 
which become SLC, invade the granulosal cells to form a heterogeneous mixture of cells in the 
CL of nonprimate species (Niswender, 2000).  Rescue of the CL during the fertile cycle by 
human chorionic gonadotropin (hCG) is essential for maintenance of pregnancy once the oocyte 
is fertilized.  Infertility is a problem that affects millions of women and their partners across the 
United States.  Causes of infertility range from ovulatory dysfunction to male related infertility 
due to abnormal sperm motility or morphology.  Insufficient luteal rescue can account for 
pregnancy loss in couples conceiving naturally as well as those that have undergone time 
consuming and expensive procedures such as intrauterine insemination or in vitro embryo 
production. 
Human granulosal cells that have been recovered during oocyte retrieval in patients 
undergoing in vitro fertilization spontaneously luteinize in culture, thus these cells have been 
used as a model to study granulosal-lutein cells of the CL (Stewart and Vandevoort, 1997).  The 
degree of luteinization of these cells has not been clearly defined, and studies using them do not 
take into account the heterogeneity of a granulosal cell population or the fertility status of the 
patient from whom they were isolated.  Using patient cause of infertility as an experimental 
variable offers a unique opportunity to study how infertility affects P4 production by luteinized 
granulosal cells when subjected to hormonal treatments. 
In multiple species, PGF2α elicits both inhibitory and stimulatory P4 responses in luteal 
cells in vitro.  Most investigators use a non-physiological dose of PGF2α when treating luteal 
cells in vitro.  The fact that PGF2α at high concentrations is able to activate the PGE2 receptor 
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could, in part, explain increases in P4 production (Rao, 1974).  Additionally, the entire 
population of cells that would normally be present in addition to luteinized granulosal cells is not 
present in all in vitro experiments.  Inhibitory action of PGF2α on human luteinized granulosal 
cells may be enhanced by presence of endothelial and/or immune cell types (Liptak et al., 2005).  
In multiple cell types, AMPK is an important regulatory protein for energy balance.  
Typically, activation of AMPK results in a shift from anabolic processes (Hardie, 2008), such as 
synthesis of proteins that are required for progesterone production, to catabolic processes.  The 
antidiabetic drug metformin activates AMPK (Viollet et al., 2012), and by 5-Aminoimidazole-4-
carboxamide-1-β-4-ribofuranoside (AICAR), a cell-permeable allosteric AMPK activator 
(Corton et al., 1995).  Dorsomorphin dihydrochloride (DM) is a potent, selective, cell-permeable 
and reversible AMPK inhibitor (Liu et al., 2014), and DM inhibited AMPK induced either by 
AICAR (Tang et al., 2011) or metformin (Isakovic et al., 2007).  Metformin is the most widely 
used drug for the treatment of type II diabetes, being prescribed to nearly 120 million people 
worldwide (Viollet et al., 2012).  Recently, metformin was used to treat women experiencing 
PCOS who were overweight or insulin resistant.  Metformin’s ability to increase insulin 
sensitivity in individuals made it an ideal candidate for the treatment of PCOS.  Metformin 
increased insulin sensitivity in patients with PCOS, and it increased ovulation rate, improved 
menstrual cyclicity, and reduced serum androgen (Tang et al., 2010).  Metformin appears to 
work in PCOS patients by both direct ovarian effects and secondarily through decreasing insulin 
resistance.  In bovine granulosal cells isolated from small antral follicles metformin has been 
shown to have effects on steroidogenesis (Tosca et al., 2007).  Metformin (10 mM) reduced both 
progesterone and estradiol production as well as key enzymes (HSD3β, CYP11A1, and STAR) 
with or without FSH and/or IGF1 in the media (Tosca et al. 2007). 
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 The goal of this project was to investigate the use of human mural granulosal and 
cumulus cells to study potential downstream targets activated by the known intracellular 
mediators, AMPK and Ca+2, of luteolytic actions of PGF2α actions in bovine luteal cells.  
Additionally, it was hypothesized that P4 stimulatory and inhibitory responses to hCG and 
PGF2α, respectively, would differ among infertility types. The objectives of this research were to 
define culture conditions and responses of luteinized human granulosal cells derived from 
patients with various infertility causes to luteotropic and luteolytic signals and to determine 
effects of increasing intracellular Ca+2 from low to high values on P4 production.  The proposed 
research had one central hypothesis: luteinized mural granulosal cells can be used to study how 
infertility influences luteal efficiency and the effects of increasing intracellular Ca+2 on P4 
production in order to determine if providing the known intracellular mediator of the best known 
luteolytic factor, PGF2α, could directly induce a reduction of P4, which is the hallmark event 
underlying luteal regression. 
Materials and Methods  
Patients 
Mural and cumulus granulosal cells from patients affected by different causes of 
infertility were provided by the WVU Center for Reproductive Medicine in Morgantown, WV 
after patient’s ovaries were stimulated for transvaginal oocyte collection for in vitro fertilization 
(IVF).  Patients ranged in age from 25-40 years of age, had a BMI range of 18.9 to 44.3, and 
presented with primary infertility types of male factor (male, n = 5), endometriosis (endo, n = 6), 
tubal factor (tub, n = 12), and unexplained/other (other, n = 3).  Daily or twice daily injections of 
recombinant follicle stimulating hormone (FSH) began on d2 or d3 of the cycle and continued 
until ovulation was induced with hCG.  Patients returned at least every other day for ultrasonic 
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monitoring of follicular growth beginning four days after stimulation.  To prevent premature 
ovulation, GnRH agonist injections began when follicles reached at least 14 mm in diameter.  
Ovulation was induced with hCG injection once follicles were ≥ 18 mm in diameter, followed by 
oocyte collection 34 h later.    
Isolation and culture of primary human GCs 
Follicular aspirates from each patient were centrifuged at 10,000 rpm for 5 min at room 
temperature.  Supernatant was discarded, and the pellet was resuspended in 500 µl of 
DMEM/F12 (Invitrogen, Grand Island, NY) with 20% (v/v) fetal bovine serum, 
insulin/transferrin/selenium B (1000; 555; 0.67 mg/L respectively; Gibco, Grand Island, NY), 
gentamicin/amphotericin (10 µg/ml-0.25µg/ml; Gibco, Grand Island, NY), and 
penicillin/streptomyocin (100 I.U./ml, 100 µg/ml; Life Technologies, Grand Island, NY).  Viable 
cell number was determined using trypan blue dye exclusion and hemocytometer.  Cells were 
plated at 10,000 cells per well in 96-well flat bottom culture plates with 300 µl DMEM/F12 
media (NUNC, Scientific Laboratory Supplies, Wilford, Nottingham, UK) at 37°C and 5% CO2 
in a humidified incubator to permit luteinization and cell attachment.  Media was changed every 
24 h whereby150 µl of spent media was replaced with fresh DMEM/F12 with serum.  Four days 
after collection, cells were transferred to serum free DMEM/F12 media, and treatments were 
administered.  Every treatment was tested in triplicate for each patient and media pooled for P4 
by radioimmunoassay (RIA) as previously described (Sheffel et al., 1982). 
 Experiment 1 
Cells were treated with PGF2α (0.1 μg/ml), human hCG (5 IU/ml), or a combination of both 
PGF2α and hCG.  Cells were cultured further for 24 h after which medium was removed and 
frozen at -20°C until assayed for P4.  Primary cause of infertility (male factor, endometriosis, 
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tubal factor, and unknown), age (< 30, 30-35, 36-40 years of age), BMI (normal = 18.5-24.9, 
overweight = 25-29.9, obese > 30), and pregnancy outcome (non-pregnant, and pregnant) were 
examined separately due to the variability among patients in these categories.   
Experiment 2 
Cells were treated with an intracellular calcium buffer 1,2-bis (o-aminophenoxy) ethane-
N,N,N',N'-tetraacetic acid,  BAPTA (500, 50, 5, 0.5 µmol, Tocris, Bristol, UK) or a calcium 
ionophore A23187 (1, 0.1, 0.01, 0.001, 0.0001, 0.00001, 0.000001 µmol, Tocris, Bristol, UK) to 
determine effects of altering intracellular Ca+2 on P4 production in luteinized human granulosal 
cells.  Treatment concentrations of BAPTA and A23187 and incubation times were based on 
previous studies with bovine luteal steroidogenic cells and preliminary studies testing 1, 3, and 
24 h incubation times in mural granulosal cells, respectively.  The medium for the control group 
contained 0.1% dimethylsufoxide (DMSO, Pierce Rockport, IL), the solvent used for BAPTA 
and A23187.  Cells were treated with BAPTA or A23187 for 1 hour, and medium was removed 
and frozen at -20°C until assayed for P4. 
Experiment 3 
Under the same culture conditions, mural granulosal cells were treated with DM (109, 10.9, 1.09, 
0.109 µm/L, Tocris, Bristol, UK) or  AICAR (7.5, 0.75, 0.075, 0.0075 mM, Tocris, Bristol, UK ) 
to evaluate the roles of inhibiting/stimulating AMPK, respectively, in luteinized mural granulosal 
cell P4 production.  Cells were cultured for further 24 h and medium was removed and frozen at 
-20°C until assayed for P4. 
Experiment 4  
Due to stimulation of P4 that was observed when cells were treated with PGF2α it was 
hypothesized that this increase was due to promiscuous binding to another PG receptor, such as 
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PGE2, which is known to increase P4.  To test this hypothesis, mural granulosal cells were 
cultured with media alone (control), PGF2α, PGF2α antagonist (AL 8810; 1.0 µmol, Cayman 
Chemical, Ann Arbor, MI), and PGF2α and AL 8810.  Preliminary dose response studies for  
AL 8810 at 10, 1, and 0.1 µmol were conducted in order to find an optimum dose for experiment 
4.  The medium for the control group contained 0.1% dimethylsufoxide (DMSO; Pierce, 
Rockport, IL), the solvent used for AL 8810. Cells were preincubated with AL 8810 for 30 min, 
treatments were administered and cells cultured for 24 hours.  Medium was collected and frozen 
at -20°C until assayed for P4.  Additionally, the effect of PGF2α and hCG on P4 production in 
cumulus cells was tested. 
Statistical Analysis  
Concentrations of P4 were tested for normal distribution via the Shapiro-Wilk test. All 
data were transformed using natural logarithm.  The one-tailed Student t-test was used to 
examine P4 production in A23187 experiments.  All other experiments were analyzed using 
ANOVA and Dunnett’s post hoc test.  Data were analyzed using JMP and SAS software (JMP®, 
Version Pro 11, SAS Institute Inc., Cary, NC, Copyright ©2013; SAS®, Version 9.3, SAS 
Institute Inc., Cary, NC, Copyright ©2002-2010). Differences were considered significant when 
P < 0.05.  Data in all graphs are depicted as the mean ± SEM. 
Results 
Experiment 1  
There was an increase in P4 production in cells treated with hCG who had been collected 
from patients that presented with male infertility factor compared to control (P = 0.0045; Figure 
3.1-A), but not in patients who presented with tubal, endometriosis, or diminished ovarian 
reserve factor (P > 0.05; Figure 3.1-B,C,D).  No significant differences in P4 were seen when 
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granulosal cells were treated with PGF2α across all infertility types (P > 0.05).  Additionally, 
hCG elicited a significant increase in P4 production in patients in the age range of 30-35 (n = 15; 
P = 0.008) and 36-40 (n = 6; P = 0.04), but not in patients in the ranges of 25-30 (n = 4; P = 
0.73) (Figure 3.2).  Patients with normal BMI (18.5-24.9, n = 16) had a significant increase in P4 
production when treated with hCG (P < 0.0001), but granulosal cells of patients who were 
categorized as overweight (BMI of 25-29.9, n = 6) or obese (BMI >30, n = 3) did not have a 
significant increase in P4 production when stimulated with hCG (P > 0.05) (Figure 3.3).  Figure 
3.4 demonstrates that granulosal cells from patients who became pregnant to the IVF cycle had 
significantly greater P4 production when stimulated with hCG (3.23 ng/ml; P = 0.0018 vs. 
control) than those who did not become pregnant (1.57 ng/ml; P > 0.05 vs. control).   
Experiment 2 
A significant reduction in P4 production was found with all concentrations of AICAR except the 
lowest (0.0075) when compared to control (P < 0.001).  However, no difference was observed 
when cells were treated with DM at any concentration (P > 0.05).  
Experiment 3 
There was a trend (P = 0.062) for PGF2α treatment to increase P4 production in mural granulosal 
cells (Figure 3.6-A).  The PGF2α receptor antagonist, AL 8810, did not block this stimulation.  
However, there was a signficant difference between controls and PGF2α and AL 8810 in 
combination (P = 0.024).  Cumulus cells responded to hCG stimulation with a signficant 
increase in P4 production (P = 0.045),  but no difference in P4 was observed when cumulus cells 
were treated with PGF2α  or PGF2α and the PG antagonist (Figure 3.6-B).   
Experiment 4 
Progesterone production was increased in mural granulosal cells by A23187 at 0.01 µmol  
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(P = 0.041), and a trend (P = 0.096) was observed at 0.1 and 1.0 µmol concentrations tested in 
comparison to control concentrations.  There was a cubic trend for the effect of BAPTA 
concentration on P4 production (P = 0.093) in mural granulosal cells.   
Discussion  
Data from experiment 1 supported the conclusion that types of infertility affect the ability 
of luteinized mural granulosal cells to respond to the luteotropic factor, hCG, in vitro.  Knowing 
the cause of a patient’s infertility prior to cell culture experiments offers a unique model to study 
how infertility affects P4 production by luteinized granulosal cells subjected to hormonal 
treatments.  Failure of these cells to respond to hCG in vivo could lead to luteal insufficiency or 
even early regression of the corpus luteum, resulting in pregnancy loss.  Implementing different 
post-implantation hormonal treatments based on specific causes of infertility could lead to 
increased pregnancy rates while keeping the number of multiple gestations low.   
Interestingly, mural cells of women who did not become pregnant had significantly lower 
P4 production when stimulated with hCG, when compared to the mural cells of pregnant women.  
Failure of these cells to secrete high levels of P4 in vivo is similar to a condition known as luteal 
phase defect (LPD).  In LPD is a brief elevation in P4 secretion (typically < 11 days) after 
ovulation, and is reported to occur in up to 20 percent of women (Balasch and Vanrell, 1987).  
This short luteal phase may be due a defect in the process of luteinization or progesterone 
production.  However, it was postulated by Strott et al. (1970) that luteal phase defect occurs as a 
result of low preovulatory FSH levels.  This leads to abnormal follicular development and 
subsequent inadequate luteinization and/or luteal function.  This condition occurs despite normal 
LH stimulation at the time of the ovulatory surge (Strott et al., 1970).  This could be the case in 
the cells from patients who did not become pregnant, where inadequate FSH levels resulted in 
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the mural granulosal cells being unable to respond to hCG.  These experiments were performed 
four days after oocyte retrieval, which is later than when embryos are normally transferred at the 
WVU CRM.  It would be interesting to stimulate cells sooner to determine if they could be used 
as a predicator of pregnancy success prior to embryo implantation.  If these cells could be used 
as a diagnostic tool, it could save patients and embryologists substantial time and monetary 
resources.   
 It was not surprising that P4 production by mural granulosal cells was affected by patient 
age.  The ability to conceive naturally, which decreases as women age; naturally decreases by 
11% from 30-34, and another 12% from ages 35-40 (Leridon, 2004).  Decreased fertility may be 
explained partially by luteal insufficiency.  The fact that luteinized mural granulosal cells did not 
respond to hCG with increases in P4 leads to the implication that luteal cells derived from these 
follicles would not respond sufficiently.  Surprisingly, the age group that did not have an 
increase in P4 production was the youngest age group.  Types of primary infertility were 
represented well in this group, but the small population size (n = 4) may explain this anomaly.  In 
contrast, it was encouraging to see that mural cells from older patients responded to luteotropic 
hCG.   
 Patients with BMIs in the overweight or obese range did not respond to hCG with 
increased P4 production.  The interrelationship between nutritional status and reproduction is 
complicated, and the mechanisms connecting the two are not well defined.  However, insulin, 
glucose, IGF-1, and leptin all impinge on follicular development directly or influence 
gonadotropins at the hypothalamic level.  As BMI and adiposity increase so do leptin, and 
insulin resistance.  It will be critical to ascertain if the mural cells of overweight and obese 
patients have insufficient substrate to produce P4 when stimulated or if they are resistant despite 
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adequate substrate.  Women with PCOS are often obese as well as insulin resistant, and are 
prescribed insulin-sensitizing medicines such as metformin (Tang et al., 2010).   
 Metformin works, in part, by activating AMPK, a key regulator of energy homeostasis 
that has direct effects on P4 production in bovine (Tosca et al., 2007), galline (Tosca et al., 2007) 
and rodent (Tosca et al., 2005) granulosal cells.  Using another AMPK activator, AICAR, a 
significant decrease in P4 was seen at all concentrations tested.  A decrease in P4 production has 
been shown in mature but not developing bovine CL, as mentioned earlier in this dissertation.  
This decrease in P4 could be explained by a decrease in key enzymes such as 3βHSD, P450scc, 
or StAR, all of which decreased in rat granulosal cells (Tosca et al., 2005).  In contrast, no 
difference in P4 production was seen when mural cells were treated with an AMPK inhibitor, 
DM.  The concentrations of DM chosen for experiment 2 were based on studies in bovine CL, in 
which DM significantly decreased P4 production.  Possibly, a greater concentration of DM was 
needed to elicit a change in P4 production in human mural granulosal cells.   
 A stimulatory effect of PGF2α has been observed consistently over time and has been 
attributed by some to the use of non-physiological doses of PGF2α in vitro, which activate other 
prostaglandin receptors (Rao et al., 1974).  Progesterone stimulation was observed in mural 
granulosal cells but not in cumulus granulosal cells (Figure 6).  A specific PGF2α receptor 
antagonist was unable to eliminate this effect in mural cells, indicating that the stimulation of P4 
production was mediated by another prostaglandin receptor.  Possibly, PGF2α is binding to PGE2 
receptors and increasing cAMP, which leads to an increase in P4.  The ability of cumulus cells to 
respond to hCG with an increased P4 indicates that, even after ovulation, hCG is capable of 
signaling the oocyte.  Human cumulus oocyte complexes express LH receptors (LHR) and up-
regulate LHR expression during the ovulatory process even though LHR expression in cumulus 
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cells is much lower than in mural granulosal cells (Jeppesen et al., 2012).  
 It is commonly accepted that increases in intracellular Ca+2 in response to FP activation 
cause a decrease in P4 production in luteal cells.  A quadratic effect on P4 production was seen 
when the calcium buffering capacity of the cells was increased by BAPTA.  Increases in 
intracellular Ca+2 were needed to support P4 production in bovine luteal cells (Alila et al., 1990).  
Concentrations of BAPTA at 5 and 50 µmol were needed before a decrease in P4 production was 
observed in experiment 4 (Figure 7).  A threshold of intracellular Ca+2, even beyond the highest 
concentration in experiment 4, may be needed to decrease P4 production.  Lower concentrations 
of BAPTA had either no effect or stimulated P4 production (Figure 7).  This result supports a 
biphasic role for Ca+2 in P4 production in human mural granulosal cells.  By pharmacologically 
increasing intracellular Ca+2 with an ionophore, A23187, basal P4 production was increased.  
This is contradictory to the findings of Goravanahally et al. (2009), in which A23187 did not 
affect basal P4 production in cultured bovine luteal cells.  Differences between species or the 
stage of luteinization could explain this difference.  Luteinized granulosal cells and luteal cells 
share several characteristics; however, they are not identical.    
 In summary, human mural granulosal cells can serve as a valuable model for 
understanding how increases in intracellular Ca+2 and its downstream targets affect P4 
production in steroidogenic cells.  Additionally, P4 production by mural granulosal cells differed 
among primary infertility type, age, BMI, and pregnancy outcome and may be used to study each 
of these factors individually.  Understanding similarities and differences between previously 
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Figure 3.1: Progesterone production by granulosal cells from patients with male factor (A), 





























































































Figure 3.2: Progesterone production in mural granulosal cells was affected by age.  Cells from 
patients who ranged in age from 25-30 (n=4) did not respond to hCG with a significant increase 
in P4 production (A).  However, cells from other age groups (31-35, n = 15 and 36-40, n = 6) 














































































   
 
 
Figure 3.3: Progesterone production in mural granulosal cells was affected by BMI.  Cells from 
patients with (A) normal BMI (18.5-24.9, n = 16) had a significant increase in P4 production 
when treated with hCG (P < 0.0001).   Cells of patients who were categorized as (B) overweight 
(BMI of 25-29.9, n = 6) or (C) obese (BMI >30, n = 3) did not have an increase in P4 production 













































































Figure 3.4:  Progesterone production in mural granulosal cells was affected by pregnancy status 
post IVF.  Luteinized mural granulosal cells from patients who became pregnant (B) to the IVF 
cycle produced significantly more P4 when stimulated with hCG than cells from those who did 
























































Figure 3.5:  The AMPK activator, AICAR, inhibited P4 production by human luteinized mural 
granulosal cells at all dosages tested (A).  In B, the AMPK inhibitor, DM, did not affect basal P4 


























































Figure 3.6: PGF2α stimulated P4 production in mural granulosal cells (A) but not in cumulus 
granulosal cells (B).  Adding a PG receptor antagonist, AL 8810, did not block stimulation in 
mural cells and had no effect in cumulus cells (A).  P4 production in cumulus cells was 
























































Figure 3.7: BAPTA had a biphasic effect on P4 production in luteinized mural granulosal cells.  










Figure 3.8:  Increases in intracellular calcium increased P4 production in mural granulosal cells.  































































Chapter 5: Literature Cited 
Acosta, T.J., Hayashi, K.G., Ohtani, M., Miyamoto, A. (2003) Local changes in blood flow 
within the preovulatory follicle wall and early corpus luteum in cows. Reprod 125 (5), 759-767 
  
Acosta, T.J., and Miyamoto, A. (2004) Vascular control of ovarian function: ovulation, corpus 
luteum formation and regression. Anim Reprod Sci 82,127-140 
 
Acosta, T.J., Yoshizawa, N., Ohtani, M., Miyamoto, A. (2002) Local Changes in Blood Flow 
Within the Early and Midcycle Corpus Luteum after Prostaglandin F2α Injection in the Cow. 
Biol Reprod 66 (3), 651-658 
 
Adams, J.M., Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. 
Science 281 (5381), 1322-1326 
 
Alila, H., Davis, J., Dowd, J., Corrodino, R., Hansel, W. (1990) Differential effects of calcium 
on progesterone production in small and large bovine luteal cells. J Ster Biochem  36 (6), 687–
693 
 
Alila, H.W., Dowd, J.P., Corradino, R.A., Harris, W.V., Hansel, W. (1988) Control of 
progesterone production in small and large bovine luteal cells separated by flow cytometry. J 
Reprod Fertil 82(2), 645-655 
 
Amini, H., Ahmadiani, A., Gazerani, P. (2005) Determination of metformin in human plasma by 
high-performance liquid chromatography. J Chromato B 824 (1), 319-322 
 
Anderson, L.E., Wu, Y.L., Tsai, S.J., Wiltbank, M.C. (2001) Prostaglandin F2α Receptor in the 
Corpus Luteum: Recent Information on the Gene, Messenger Ribonucleic Acid, and Protein. 
Biol Reprod 64 (4), 1041-1047 
 
Atli, M.O., Bender, R.W., Mehta, V., Bastos, M.R., Luo, W., Vezina, C.M., and Wiltbank, M.C. 
(2012) Patterns of Gene Expression in the Bovine Corpus Luteum Following Repeated Intra-
Uterine Infusions of Low Doses of Prostaglandin F2alpha. Biol Reprod 86 (4) 130, 1-13 
 
Auletta, F.J., Flint, A.P.F. (1988) Mechanisms controlling corpus luteum function in sheep, 
cows, non-human primates, and women, especially in relation to the time of luteolysis. Endocrin 
Rev 9 88–105 
 
Auletta, F.J., Kamps, D.L., Pories, S., Bisset, J., Gibson, M. (1984) An intra-corpus luteum site 
for the luteolytic action of prostaglandin F2 alpha in the rhesus monkey. Prostaglandins 27 (2), 
285-298 
 





Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C., Mclauchlan, H., Klevernic, I., Arthur, J., 
Alessi, D., Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. 
Biochem J 408, 297-315 
 
Balasch, J. & Vanrell, J. A. 1987. Corpus luteum insufficiency and fertility: a matter of 
controversy. Hum Reprod, 2, 557-567. 
 
Bateman, A. (1997) The structure of a domain common to archaebacteria and the homocystinuria 
disease protei. Trend Biochem Sci 22 (1), 12-13 
 
Bauer, M., Reibiger, I., Spanel-Borowski, K. (2001) Leucocyte proliferation in the bovine corpus 
luteum. Reprod 121(2), 297-305 
 
Behrman, H.R., Greep, R.O. (1972) Hormonal dependence of cholesterol ester hydrolase in the 
corpus luteum and adrenal. Horm Metabol Res 4(3), 206-209 
 
Behrman, H.R., Luborsky-Moore, J.L., Pang, C.Y., Wright, K., Dorflinger, L.J. (1979) 
Mechanisms of PGF2α action in functional luteolysis. Adv Exp Med Biol 112, 557-575 
 
Belfort, R. Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, 
A., Tio, F., Pulcini, J., Berria, R., Ma, J.Z., Dwivedi, S., Havranek, R., Fincke, C., DeFronzo, R., 
Bannayan, G.A., Schenker, S., Cusi, K. (2006) A placebo-controlled trial of pioglitazone in 
subjects with nonalcoholic steatohepatitis. New Eng J Med (22), 2297-2307 
 
Beling, C.G., Marcus, S.L., Markham, S.M. (1970) Functional Activity of the Corpus Luteum 
Following Hysterectomy. J Clin Endocrinol Metabol 30 (1), 30-39 
 
Benyo, D.F., Pate, J.L. (1992) Tumor necrosis factor-alpha alters bovine luteal cell synthetic 
capacity and viability. Endocrinology 130 (2), 854-860 
 
Berardinelli, J.G., Dailey, R.A., Butcher, R.L., Inskeep, E.K. (1979) Source of Progesterone 
Prior to Puberty in Beef Heifers. J Anim Sci 49 (5), 1276-1280 
 
Berisha, B., Schams, D., Kosmann, M., Amselgruber, W., Einspanier, R. (2000) Expression and 
Tissue Concentration of Vascular Endothelial Growth Factor, Its Receptors, and Localization in 
the Bovine Corpus Luteum During Estrous Cycle and Pregnancy. Biol Reprod 63 (4), 1106-1114 
 
Berisha, B., Steffl, M., Amselgruber, W., Schams, D. (2006) Changes in fibroblast growth factor 
2 and its receptors in bovine follicles before and after GnRH application and after ovulation. 
Reproduction 131 (2), 319-329 
 
Berridge, M., J., Dawson, R.M., Downes, C.P., Heslop, J.P., Irvine, R. (1983) Changes in the 
levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. 




Berridge, M.J. (1987) Inositol trisphosphate and diacylglycerol: two interacting second 
messengers. Annu Rev Biochem 56, 159-93 
 
Bogan, R.L., Hennebold, J.D. (2010) The reverse cholesterol transport system as a potential 
mediator of luteolysis in the primate corpus luteum. Reproduction 139 (1), 163-176 
Bogan, R.L., Murphy, M.J., Hennebold, J.D. (2009) Dynamic changes in gene expression that 
occur during the period of spontaneous functional regression in the rhesus macaque corpus 
luteum. Endocrinology 150 (3), 1521-1529 
 
Boris, M., Kaiser, C.C., Goldblatt, A., Elice, M.W., Edelson, S.M., Adams, J.B., Feinstein, D.L. 
(2007) Effect of pioglitazone treatment on behavioral symptoms in autistic children. . J 
Neuroinflammation 4 (3) 
 
Bowen-Shauver, J.M., Telleria, C.M. (2003) Luteal regression: a redefinition of the terms. 
Reprod Biol and Endocrinol 1 (1), 28 
 
Braden, T.D., Gamboni, F., Niswender, G.D. (1988) Effects of prostaglandin F2 alpha-induced 
luteolysis on the populations of cells in the ovine corpus luteum. Biol Reprod 39 (2), 245-253 
 
Brown, M., Goldstein, J. (1975) Regulation of the activity of the low density lipoprotein receptor 
in human fibroblasts. Cell 6, 307–3l6 
 
Brown, M.S., Dana, S.E., Goldstein, J.L. (1975) Cholesterol ester formation in cultured human 
fibroblasts. Stimulation by oxygenated sterols. J of Biol Chem 250 (10), 4025-4027 
 
Brown, M.S., Goldstein, J.L. (1979) Receptor-mediated endocytosis: insights from the 
lipoprotein receptor system. PNAS 76 (7), 3330-3337 
 
Buccione, R., Schroeder, A.C., Eppig, J.J. (1990) Interactions between somatic cells and germ 
cells throughout mammalian oogenesis. Biol Reprod 43 (4), 543-547 
 
Casella, S., Schryver, D.J., Scott, T., Pflugheber, J., Bodensteiner, K.J. (2005) 
Immunohistochemical Localization of Basement Membrane Proteins in Rat Ovarian Follicles. 
Microscop and Microanal 11(Supplement S02), 108-109 
 
Casida LE. Research techniques in physiology of reproduction in the female. In: Chapman AB, 
editor. Techniques and procedures in animal production research. American Society of Animal 
Production, Albany; 1959. p. 106–21. 
 
Chaffkin, L.M., Luciano, A.A., and Peluso, J.J. (1992) Progesterone as an autocrine/paracrine 
regulator of human granulosa cell proliferation. . J Clin Endocrinol & Metabol 75 (6), 1404-
1408 
 
Choi, J., Jo, M., Lee, E., Choi, D. (2011a) The Role of Autophagy in Corpus Luteum Regression 
in the Rat. Biol Reprod 85 (3), 465-472 
 
 76 
Choudhary, E., Sen, A., Inskeep, E.K., Flores, J.A. (2005) Developmental Sensitivity of the 
Bovine Corpus Luteum to Prostaglandin F2α (PGF2α) and Endothelin-1 (ET-1): Is ET-1 a 
Mediator of the Luteolytic Actions of PGF2α or a Tonic Inhibitor of Progesterone Secretion? 
Biol Reprod 72 (3), 633-642 
 
Corton, J.M., Gillespie, J.G., Hawley, S.A., Hardie, D.G. (1995) 5‐Aminoimidazole‐4‐
Carboxamide Ribonucleoside. Eur J Biochem 229 (2), 558-565 
 
Davis, J.S., Alila, H.W., West, L.A., Corradino, R.A., Hansel, W. (1988) Acute effects of 
prostaglandin F2α on inositol phospholipid hydrolysis in the large and small cells of the bovine 
corpus luteum. Mole Cell Endocrinol 58 (1), 43-50 
 
Davis, J.S., Rueda, B.R. (2002) The corpus luteum: an ovarian structure with maternal instincts 
and suicidal tendencies. Front Biosci 7, d1949-1978 
 
Davis, J.S., Weakland, L.L., Weiland, D.A., Farese, R.V., West, L.A. (1987) Prostaglandin F2 
alpha stimulates phosphatidylinositol 4,5-bisphosphate hydrolysis and mobilizes intracellular 
Ca2+ in bovine luteal cells. PNAS 84 (11), 3728-3732 
 
Dharmarajan, A.M., Bruce, N.W., Meyer, G.T. (1985) Quantitative ultrastructural characteristics 
relating to transport between luteal cell cytoplasm and blood in the corpus luteum of the pregnant 
rat. Am J Anat 172 (1), 87-99 
 
Eppig, J.J. (2001) Oocyte control of ovarian follicular development and function in mammals. 
Reproduction 122 (6), 829-838 
 
Fairchild, D.L., Pate, J.L. (1991) Modulation of bovine luteal cell synthetic capacity by 
interferon-gamma. Biol Reprod 44 (2), 357-363 
 
Fairclough, R.J., Moore, L.G., McGowan, L.T., Peterson, A.J., Smith, J.F., Tervit, H.R., 
Watkins, W.B. (1980) Temporal relationship between plasma concentrations of 13, 14-dihydro-
15-keto-prostaglandin F and neurophysin I/II around luteolysis in sheep. . Prostaglandins 20 (2), 
199-208 
 
Farin, C.E., Moeller, C.L., Sawyer, H.R., Gamboni, F., Niswender, G.D. (1986) Morphometric 
analysis of cell types in the ovine corpus luteum throughout the estrous cycle. Biol Reprod 35 
(5), 1299-1308 
 
Flint, A.P.F., Sheldrick, E.L. (1982) Ovarian secretion of oxytocin is stimulated by 
prostaglandin. Nature 29 (5867), 587-588 
 
Friedrich, F., Kemeter, P., Salzer, H., Breitenecker, G. (1975) Ovulation inhibition with human 





Garrido, C., Saule, S., Gospodarowicz, D. (1993) Transcriptional regulation of vascular 
endothelial growth factor gene expression in ovarian bovine granulosa cells. . Growth factors 8 
(2), 109-117 
 
Ginther, O.J., Shrestha, H.K., Fuenzalida, M.J., Shahiduzzaman, A.K.M., Beg, M.A. (2010) 
Characteristics of Pulses of 13,14-Dihydro-15-Keto-Prostaglandin F2alpha Before, During, and 
after Spontaneous Luteolysis and Temporal Intrapulse Relationships with Progesterone 
Concentrations in Cattle. Biol Reprod 82 (6), 1049-1056 
 
Ginther, O.J., Silva, L.A., Araujo, R.R., Beg, M.A. (2007) Temporal Associations among Pulses 
of 13,14-Dihydro-15-keto-PGF2alpha, Luteal Blood Flow, and Luteolysis in Cattle. Biol Reprod 
76 (3), 506-513 
 
Girsh, E., Greber, Y., Meidan, R. (1995) Luteotrophic and luteolytic interactions between bovine 
small and large luteal-like cells and endothelial cells. Biol Reprod 52 (4), 954-962 
 
Goldstein, J.L., and Brown, M.S. (2009) The LDL Receptor. Arterio, Throm, and Vascul Biol  
29 (4), 431-438 
 
Goravanahally, M.P., Salem, M., Yao, J., Inskeep, E.K., Flores, J.A. (2009) Differential Gene 
Expression in the Bovine Corpus Luteum During Transition from Early Phase to Midphase and 
Its Potential Role in Acquisition of Luteolytic Sensitivity to Prostaglandin F2 Alpha. Biol Reprod 
80 (5), 980-988 
 
Goravanahally, M.P., Sen, A., Inskeep, E.K., Flores, J.A. (2007) PKCepsilon and an increase in 
intracellular calcium concentration are necessary for PGF2alpha to inhibit LH-stimulated 
progesterone secretion in cultured bovine steroidogenic luteal cells. Reprod Biol Endocrinol  
5 (37) 
 
Goyeneche, A.A., Calvo, V., Gibori, G., Telleria, C.M. (2002) Androstenedione Interferes in 
Luteal Regression by Inhibiting Apoptosis and Stimulating Progesterone Production. Biol 
Reprod 66 (5), 1540-1547 
 
Gruzman, A., Babai, G., Sasson, S. (2009) Adenosine Monophosphate-Activated Protein Kinase 
(AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and 
Chemical Considerations. Rev Diabet Stud 6 (1), 13-36 
 
Guraya, S.S. (1971) Morphology, histochemistry, and biochemistry of human ovarian 
compartments and steroid hormone synthesis. Physiol Rev 51, 785-807 
 
Gutierrez, C.G., Ralph, J.H., Telfer, E.E., Wilmut, I.,Webb, R. (2000) Growth and Antrum 






Hansen, T.R., Randel, R.D., Segerson, E.C., Rutter, L.M., Harms, P.G. (1987) Corpus Luteum 
Function Following Spontaneous or Prostaglandin-Induced Estrus in Brahman Cows and 
Heifers. J Anim Sci 65 (2), 524-533 
 
Hardie, D.G. (2008) AMPK: a key regulator of energy balance in the single cell and the whole 
organism. Int J Obes 32 (S4), S7-S12 
Hardie, D.G., Ross, F.A., Hawley, S.A. (2012) AMPK: a nutrient and energy sensor that 
maintains energy homeostasis. Nat Rev Mol Cell Biol 13 (4), 251-62 
 
Hearn, J.P., Webley, G.E., Gidley-Baird, A.A. (1991) Chorionic gonadotrophin and embryo-
maternal recognition during the peri-implantation period in primates. J Reprod Fertil 92 (2), 
497-509 
 
Hild-petito, S., Stouffer, R.L., and Brenner, R.M. (1988) Immunocytochemical Localization of 
Estradiol and Progesterone Receptors in the Monkey Ovary Throughout the Menstrual 
Cycle Endocrinology 123 (6), 2896-2905 
 
Hou, X., Arvisais, E.W., Davis, J.S. (2010) Luteinizing hormone stimulates mammalian target of 
rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-
activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein 
kinase. Endocrinology 151 (6), 2846-2857 
 
Hoyer, P.B., Fitz, T.A., Niswender, G.D. (1984) Hormone-Independent Activation of Adenylate 
Cyclase in Large Steroidogenic Ovine Luteal Cells Does Not Result in Increased Progesterone 
Secretion. Endocrinology 114 (2), 604-608 
 
Hsueh, A.J., Adashi, E.Y., Jones, P.B., and Welsh JR, T.H. (1984) Hormonal Regulation of the 
Differentiation of Cultured Ovarian Granulosa Cells Endocrin Rev 5 (1), 76-127 
 
Hu, J., Zhang, Z., Shen, W.J., Azhar, S. (2010) Review Cellular cholesterol delivery, 
intracellular processing and utilization for biosynthesis of steroid hormones. Nut Metabol 7,  
47-72. 
 
Hustace, J.L., Firshman, A.M., Mata, J.E. (2009) Pharmacokinetics and bioavailability of 
metformin in horses. Am J Vet Res 70 (5), 665-668 
 
Inskeep, E.K. (1973) Potential Uses of Prostaglandins in Control of Reproductive Cycles of 
Domestic Animals. J Anim Sci 36 (6), 1149-1157 
 
Isakovic, A., Harhaji, L., Stevanovic, D., Markovic, Z., Sumarac-Dumanovic, M., Starcevic, V., 
Micic, D., Trajkovic, V. (2007) Dual antiglioma action of metformin: cell cycle arrest and 






Jeppesen, J.V., Kristensen, S.G., Nielsen, M.E., Humaidan, P., Dal Canto, M., Fadini, R., 
Schmidt, K.T., Ernst, E., Yding Andersen, C. (2012) LH-Receptor Gene Expression in Human 
Granulosa and Cumulus Cells from Antral and Preovulatory Follicles. J Clin Endocrinol 
Metabol 97(8), E1524- E1531  
 
Juengel, J.L., Garverick, H.A., Johnson, A.L., Youngquist, R.S., Smith, M.F. (1993) Apoptosis 
during luteal regression in cattle. Endocrinology 132 (1), 249-254 
 
Juengel, J.L., Melner, M.H., Clapper, J.A., Turzillo, A.M., Moss, G.E., Nett, T.M., Niswender, 
G.D. (1998) Steady-state concentrations of mRNA encoding two inhibitors of protein kinase C in 
ovine luteal tissue. J Reprod Fertil 113 (2), 299-305 
 
Kang, J.H. (2014) Protein Kinase C (PKC) Isozymes and Cancer. New J Sci 
 
Keisler, D.H., Keisler, L.W. (1989) Formation and function of GnRH-induced subnormal 
corpora lutea in cyclic ewes. J Reprod Fertil 87 (1), 265-273 
 
Kerr, J.F., Wyllie, A.H., Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with 
wide-ranging implications in tissue kinetics. Brit J Can 26 (4), 239 
 
Keyes, P., Gadsby, J., Yuh, K., Bill, C.r. (1983) The corpus luteum. Int Rev Physiol 27, 57-97 
 
Kim, J., Kundu, M., Viollet, B., Guan, K.L. (2011) AMPK and mTOR regulate autophagy 
through direct phosphorylation of Ulk1. Nat Cell Biol 1 3(2), 132-141 
 
Kindahl, H., Edqvist, L.E., Granstrom, E., Bane, A. (1976) The release of prostaglandin F2α as 
reflected by 15-keto-13, 14-dihydroprostaglandin F2α in the peripheral circulation during normal 
luteolysis in heifers. Prostaglandins 11, 871-876 
 
Kliem, H., Berisha, B., Meyer, H.H.D., Schams, D. (2009) Regulatory changes of apoptotic 
factors in the bovine corpus luteum after induced luteolysis. Mol Reprod Dev 76 (3), 220-230 
 
Klionsky, D.J., Emr, S.D. (2000) Autophagy as a regulated pathway of cellular degradation. 
Science 290 (5497), 1717-1721 
 
Knickerbocker, J.J., Wiltbank, M.C., Niswender, G.D. (1988) Mechanisms of luteolysis in 
domestic livestock. . Dom Anim Endocrinol 5 (2), 91-107 
 
Ko, C., Gieske, M.C., Al-Alem, L., Hahn, Y., Su, W., Gong, M.C., Iglarz, M., Koo, Y. (2006) 
Endothelin-2 in Ovarian Follicle Rupture. Endocrinology 147 (4), 1770-1779 
 
Kobayashi, S., Berisha, B., Amselgruber, W.M., Schams, D., Miyamoto, A. (2001) Production 
and localisation of angiotensin II in the bovine early corpus luteum: a possible interaction with 




Kotwica, J., Rekawiecki, R., Duras, M. (2004) Stimulatory influence of progesterone on its own 
synthesis in bovine corpus luteum. Bull Vet Inst Pulawy 48 (2), 139-146 
 
Kotwica, J., Skarzynski, D. (1993) Influence of oxytocin removal from the corpus luteum on 
secretory function and duration of the oestrous cycle in cattle. J Reprod Fertil 97 (2), 411-417 
 
Lee, J., McCracken, J.A., Banu, S.K., Arosh, J.A. (2013) Intrauterine Inhibition of Prostaglandin 
Transporter Protein Blocks Release of Luteolytic PGF2alpha Pulses Without Suppressing 
Endometrial Expression of Estradiol or Oxytocin Receptor in Ruminants. Biol Reprod 89 (2), 27 
 
Legro, R., Barnhart, H., Schlaff, W., Carr, B., Diamond, M., Carson, S., Steinkampf, M., 
Coutifaris, C., McGovern, P., Cataldo, N., Gosman, G., Nestler, J., Giudice, L., Ewens, K., 
Spielman, R., Leppert, P., Myers, E. (2008) Ovulatory Response to Treatment of Polycystic 
Ovary Syndrome Is Associated with a Polymorphism in the STK11 Gene. J Clin Endocrinol 
Metabol 93 (3), 792-800 
 
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., 
Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. 
E., Giudice, L. C., Leppert, P. C. & Myers, E. R. Clomiphene, Metformin, or Both for Infertility 
in the Polycystic Ovary Syndrome. N Engl J Med, 356, 551-566 
 
Leridon, H. (2004) Can assisted reproduction technology compensate for the natural decline in 
fertility with age? A model assessment. Human Reprod 19 (7), 1548-1553 
 
Lestavel, S., Fruchart, J.C. (1994) Lipoprotein receptors. Cell Mol Biol 40 (4), 461-481 
 
Liptak, A.R., Sullivan, B.T., Henkes, L.E., Wijayagunawardane, M.P.B., Miyamoto, A., Davis, 
J.S., Rueda, B.R., Townson, D.H. (2005) Cooperative Expression of Monocyte Chemoattractant 
Protein 1 Within the Bovine Corpus Luteum: Evidence of Immune Cell-Endothelial Cell 
Interactions in a Coculture System. Biol Reprod 72 (5), 1169-1176 
 
Liu, X., Chhipa, R.R., Nakano, I., Dasgupta, B. (2014) The AMPK Inhibitor Compound C Is a 
Potent AMPK-Independent Antiglioma Agent. Mol Can Therap 13 (3), 596-605 
 
Liu, Y.X., Hsueh, A.J. (1986) Synergism between granulosa and theca-interstitial cells in 
estrogen biosynthesis by gonadotropin-treated rat ovaries: studies on the two-cell, two-
gonadotropin hypothesis using steroid antisera. Biol Reprod 35 (1), 27-36 
 
Lucy, M.C., Stevenson, J.S., Call, E.P. (1986) Controlling First Service and Calving Interval by 
Prostaglandin F2α, Gonadotropin-Releasing Hormone, and Timed Insemination. J Dairy Sci 
69 (8), 2186-2194 
 
Mamluk, R., Chen, D., Greber, Y., Davis, J.S., Meidan, R. (1998) Characterization of messenger 
ribonucleic acid expression for prostaglandin F2 alpha and luteinizing hormone receptors in 
various bovine luteal cell types. Biol Reprod 58 (3), 849-856 
 
 81 
Mann, G.E., Lamming, G.E. (2006) Timing of prostaglandin F2α release episodes and oxytocin 
receptor development during luteolysis in the cow. Anim Reprod Sci 93 (3), 328-336 
 
Martin, G.G., Talbot, P. (1981) The role of follicular smooth muscle cells in hamster ovulation. J 
Exp Zool 216 (3), 469-482 
 
Martin, S.J., Green, D.R. (1995) Protease activation during apoptosis: death by a thousand cuts? 
Cell 82 (3), 349-352 
 
Matsui, M., Miyamoto, A. (2009) Evaluation of ovarian blood flow by colour Doppler 
ultrasound: practical use for reproductive management in the cow. Vet J 181 (3), 232-240 
 
McCracken, J.A. (1971) Prostaglandin F2α and corpus luteum regression. Ann NY Acad Sci  
180 (1), 456-469 
 
McCracken, J.A., Custer, E.E., Eldering, J.A., Robinson, A.G. (1996) The central oxytocin pulse 
generator: a pacemaker for the ovarian cycle. Acta Neurobiol Exp 56 (3), 819-832 
 
McCracken, J.A., Custer, E.E., Lamsa, J.C. (1999) Luteolysis: a neuroendocrine-mediated 
event. Physiol Rev 79 (2), 263-323 
 
McNatty, K.P., Makris, A., Degrazia, C., Rapin, O., Ryan, K.J. (1979) The Production of 
Progesterone, Androgens, and Estrogens by Granulosa Cells, Thecal Tissue, and Stromal Tissue 
from Human Ovaries in Vitro. J Clin Endocrinol Metabol 49 (5), 687-699 
 
Merrill, G., Kurth, E., Hardie, D., Winder, W. (1997) AICA riboside increases AMP-activated 
protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Amer J Physiol Endocrinol 
Metabol 273 (6), E1107-E1112 
 
Milvae, R.A., Hansel, W. (1983) Prostacyclin, prostaglandin F2 alpha and progesterone 
production by bovine luteal cells during the estrous cycle. Biol Reprod 29 (5), 1063-1068 
 
Miyamoto, A., Shirasuna, K., Wijayagunawardane, M.P.B., Watanabe, S., Hayashi, M., 
Yamamoto, D., Matsui, M., Acosta, T.J. (2005) Blood flow: a key regulatory component of 
corpus luteum function in the cow. Dom Anim Endocrinol 29 (2), 329-339 
 
Morales, C., García-Pardo, L., Reymundo, C., Bellido, C., Sánchez-Criado, J.E., Gaytán, F. 
(2000) Different patterns of structural luteolysis in the human corpus luteum of menstruation. 
Human Reprod 15( 10), 2119-2128 
 
Nagata, S. (1997) Apoptosis by death factor. Cell 88 (3), 355-365 
 
Nett, T.M., McClellan, M.C., Niswender, G.D. (1976) Effects of Prostaglandins on the Ovine 




Neuvians, T.P., Schams, D., Berisha, B., Pfaffl, M.W. (2004) Involvement of Pro-Inflammatory 
Cytokines, Mediators of Inflammation, and Basic Fibroblast Growth Factor in Prostaglandin 
F2α-Induced Luteolysis in Bovine Corpus Luteum. Biol Reprod 70 (2), 473-480 
 
Niswender, G., Nett, T. (1994) Corpus luteum and its control in infraprimate species. In 'The 
Physiology of Reproduction.' (Eds. E Knobil and JD Neil). (Raven Press: New York) 
 
Niswender, G.D. (2002) Molecular control of luteal secretion of progesterone. Reproduction 123 
(3), 333-339 
 
Niswender, G.D., Juengel, J.L., Silva, P.J., Rollyson, M.K., McIntush, E.W. (2000) Mechanisms 
Controlling the Function and Life Span of the Corpus Luteum. Physiol Rev 80 (1), 1-29 
 
O'Shea, J.D., Cran, D.G., Hay, M.F. (1979) The small luteal cell of the sheep. J Anat 128 (2), 
239-251 
Papadopoulos, V., Amri, H., Boujrad, N., Cascio, C., Culty, M., Garnier, M., Hardwick, M., 
Drieu, K. (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. 
Ster 62 (1), 21-28 
 
Park, S.H., Gammon, S.R., Knippers, J.D., Paulsen, S.R., Rubink, D.S., Winder, W.W. (2002) 
Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl 
Physiol 92 (6), 2475-2482 
 
Pate, J.L. (1988a) Regulation of prostaglandin synthesis by progesterone in the bovine corpus 
luteum. Prostaglandins 36 (3), 303-315 
 
Pate, J.L. (1995) Involvement of immune cells in regulation of ovarian function. J Reprod Fertil 
Supplement 49 365-377 
 
Patton, P.E., and Stouffer, R.L. (1991) Current understanding of the corpus luteum in women 
and nonhuman primates. . Clini Obstet Gynecol 34 (1), 127-143 
 
Peluso, J.J. (1997) Placing progesterone in the apoptotic pathway. Trends Endocrinol Metabol  
8 (7), 267-271 
 
Penny, L.A. (2000) Monocyte chemoattractant protein 1 in luteolysis. Rev Reprod 5(2), 63-66 
 
Penny, L.A., Armstrong, D., Bramley, T.A., Webb, R., Collins, R.A., Watson, E.D. (1999) 
Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle 
and after induced luteolysis. J Reprod Fertil 115 (1), 87-96 
 
Piper, P.J., Vane, J.R., Wyllie, J.H. (1970) Inactivation of prostaglandins by the lungs. Nature 
225 (5233), 600-604 
 
Pursley, J.R., Mee, M.O., Wiltbank, M.C. (1995) Synchronization of ovulation in dairy cows 
using PGF2α and GnRH. Theriogenology 44 (7), 915-923 
 83 
Rao, C.V. (1974) Characterization of Prostaglandin Receptors in the Bovine Corpus Luteum Cell 
Membranes. J Biol Chem 249( 22), 7203-7209 
 
Redmer, D.A., Reynolds, L.P. (1996) Angiogenesis in the ovary. Rev Reprod 1 (3), 182-192 
 
Rendle, D.I., Rutledge, F., Hughes, K.J., Heller, J., Durham, A.E. (2013) Effects of metformin 
hydrochloride on blood glucose and insulin responses to oral dextrose in horses. Equine Vet J 45 
(6), 751-754 
 
Reynolds, L.P., Grazul-Bilska, A., Killilea, S., Redmer, D. (1994) Mitogenic factors of corpora 
lutea. Prog Growth Fact Res 5 (2), 159-175 
 
Reynolds, L.P., Grazul-Bilska, A.T., Redmer, D.A. (2000) Angiogenesis in the corpus luteum. 
Endocrine 12 (1), 1-9 
Roberts, R.M., Xie, S., Mathialagan, N. (1996) Maternal recognition of pregnancy. Biol Reprod 
54 (2), 294-302 
 
Robertson, J.E., Baker, R.D., (1969) Role of female sex steroids on possible regulation of oocyte 
maturation. Second Annual Meeting of the Society for the Study of Reproduction, University of 
California, Davis (Abstract 57) 
 
Robinson, R.S., Hammond, A.J., Mann, G.E., Hunter, M.G. (2008) A novel physiological culture 
system that mimics luteal angiogenesis. Reproduction 135 (3), 405-413 
 
Robinson, R.S., Nicklin, L.T., Hammond, A.J., Schams, D., Hunter, M.G., Mann, G.E. (2007) 
Fibroblast Growth Factor 2 Is More Dynamic than Vascular Endothelial Growth Factor A 
During the Follicle-Luteal Transition in the Cow. Biol Reprod 77 (1), 28-36 
 
Robinson, R.S., Woad, K.J., Hammond, A.J., Laird, M., Hunter, M.G., Mann, G.E. (2009) 
Angiogenesis and vascular function in the ovary. Reproduction 138 (6), 869-881 
 
Rodgers, R.J., Irving-Rodgers, H.F. (2010) Formation of the Ovarian Follicular Antrum and 
Follicular Fluid. Biol Reprod 82 (6), 1021-1029 
 
Rothchild, I. (1981) The regulation of the mammalian corpus luteum Rec Prog Horm Res 37, 
183–298 
 
Rowson, L., Trevit, R., Brand, A. (1972) The use of prostaglandins for synchronizationof oestrus 
in cattle. J Reprod Fertil 29(145 (abstract)) 
 
Rueda, B., Hamernik, D., Hoyer, P., Tilly, J. (1997) Potential regulators of physiological cell 
death in the corpus luteum  In 'Serono Symposia: Cell Death in Reproductive Physiology.'. (Eds. 





Rueda, B.R., Hendry, I.R., Hendry, W.J., Stormshak, F., Slayden, O.D., Davis, J.S. (2000) 
Decreased Progesterone Levels and Progesterone Receptor Antagonists Promote Apoptotic Cell 
Death in Bovine Luteal Cells. Biol Reprod 62 (2), 269-276 
 
Russell, D.L., Salustri, A. (2006) Extracellular matrix of the cumulus-oocyte complex. Sem 
Reprod Med 24 (4), 217-227 
 
Sawyer, H.R., Niswender, K.D., Braden, T.D., Niswender, G.D. (1990) Nuclear changes in ovine 
luteal cells in response to PGF2α. Dom Anim Endocrinol 7 (2), 229-237 
 
Scaramuzzi, R.J., Baird, D.T., Campbell, B.K., Driancourt, M.A., Dupont, J., Fortune, J.E., 
Gilchrist, R.B., Martin, G.B., McNatty, K.P., McNeilly, A.S., Monget, P., Monniaux, D., 
Viñoles, C., Webb, R. (2011) Regulation of folliculogenesis and the determination of ovulation 
rate in ruminants. . Reprod Fertil Dev 23, 444–467 
 
Schams, D., Amselgruber, W., Einspanier, R., Sinowatz, F., Gospodarowicz, D. (1994) 
Localization and tissue concentration of basic fibroblast growth factor in the bovine corpus 
luteum. Endocrine 2: 907-912 
 
Schuster, V.L. (1998) Molecular mechanisms of prostaglandin transport. Ann Rev Physiol 60 (1), 
221-242 
 
Sen, A., Browning, J., Inskeep, E.K., Lewis, P., Flores, J.A. (2004) Expression and Activation of 
Protein Kinase C Isozymes by Prostaglandin F2α in the Early- and Mid-Luteal Phase Bovine 
Corpus Luteum. Biol Reprod 70 (2), 379-384 
 
Sen, A., Choudhary, E., Inskeep, E.K., Flores, J.A. (2005) Effects of Selective Protein Kinase C 
Isozymes in Prostaglandin2α-Induced Ca2+ Signaling and Luteinizing Hormone-Induced 
Progesterone Accumulation in the Mid-Phase Bovine Corpus Luteum. Biol Reprod 72 (4), 976-
984 
 
Shah, D.K., Menon, K.M.J., Cabrera, L.M., Vahratian, A., Kavoussi, S.K., Lebovic, D.I. (2010) 
Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human 
luteinized granulosa cells in vitro. Fertil Steril 93 (6), 2042-2047 
 
Shapiro, S.S., Wilk, M.B. (1965) An Analysis of Variance Test for Normality (Complete 
Samples). Biometrika 52 (3/4), 591-611 
 
Sheffel, C.E., Pratt, B.R., Ferrell, W.L., Inskeep, E.K. (1982) Induced Corpora Lutea in the 
Postpartum Beef Cow. II. Effects of Treatment with Progestogen and Gonadotropins. J Anim Sci 
54 (4), 830-836 
 
Shirasuna, K., Jiemtaweeboon, S., Raddatz, S., Nitta, A., Schuberth, H.J., Bollwein, H., Shimizu, 
T., Miyamoto, A. (2010) Rapid accumulation of polymorphonuclear neutrophils in the corpus 
luteum during prostaglandin F2α-induced luteolysis in the cow. PloS One 7 (1), e29054 
 
 85 
Short, R.V. (1962) Steroids in the follicular fluid and the corpus luteum of the mare. A 'two-cell 
type' theory of ovarian steroid synthesis. J Endocrinol 24(1), 59-63 
 
Silvia, W.J., Lewis, G.S., McCracken, J.A., Thatcher, W.W., Wilson, L. (1991) Hormonal 
regulation of uterine secretion of prostaglandin F2 alpha during luteolysis in ruminants. Biol 
Reprod 45 (5), 655-663 
 
Siperstein, M. (1970) Regulation of cholesterol biosynthesis in normal and malignant tissues. 
Curr Top Cell Reg 2, 65–l00 
 
Smith, G.D., Sawyer, H.R., Mirando, M.A., Griswold, M.D., Sadhu, A., Reeves, J.J. (1996) 
Steady-state luteinizing hormone receptor messenger ribonucleic acid levels and endothelial cell 
composition in bovine normal- and short-lived corpora lutea. Biol Reprod 55 (4), 902-909 
 
Stevenson, J.S., Pursley, J.R. (1994) Use of Milk Progesterone and Prostaglandin F2α in a 
Scheduled Artificial Insemination Program. J Dairy Sci 77(6), 1755-1760 
 
Stewart, D.R., aVandevoort, C.A. (1997) Simulation of human luteal endocrine function with 
granulosa lutein cell culture J Clin Endocrinol Metabol 82 (9), 3078 
 
Stouffer, R.L. (2003) Progesterone as a mediator of gonadotrophin action in the corpus luteum: 
beyond steroidogenesis. Human Reprod Update 9 (2), 99-117 
 
Strott, C. A., Cargille, C. M., Ross, G. T. & Lipsett, M. B. 1970. The Short Luteal Phase. J Clinc 
Endocrin Metabol, 30,246-251. 
 
Sugino, N., Telleria, C.M., Gibori, G. (1997) Progesterone inhibits 20α-hydroxysteroid 
dehydrogenase expression in the rat corpus luteum through the glucocorticoid 
receptor. Endocrinology 138 (10), 4497-4500 
 
Suzuki, T., Sasano, H., Kimura, N., Tamura, M., Fukaya, T., Yajima, A., Nagura, H. (1994) 
Physiology: Immunohistochemical distribution of progesterone, androgen and oestrogen 
receptors in the human ovary during the menstrual cycle: relationship to expression of 
steroidogenic enzymes. Human Reprod 9 (9), 1589-1595 
 
Tanabe, T.Y., Hann, R.C. (1984) Synchronized Estrus and Subsequent Conception in Dairy 
Heifers Treated with Prostaglandin F2α. I. Influence of Stage of Cycle at Treatment. J Anim Sci 
58 (4), 805-811 
 
Tang, T., Lord, J., Norman, R., Yasmin, E., Balen, A. (2010) Insulin-sensitising drugs 
(metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary 
syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Syst Rev 4 
 
Tang, Y.C., Williams, B.R., Siegel, J.J., Amon, A. (2011) Identification of aneuploidy-selective 
antiproliferation compounds. Cell 144 (4), 499-512 
 
 86 
Tosca, L., Chabrolle, C., Uzbekova, S., Dupont, J. (2007) Effects of Metformin on Bovine 
Granulosa Cells Steroidogenesis: Possible Involvement of Adenosine 5′ Monophosphate-
Activated Protein Kinase (AMPK). Biol Reprod 76 (3), 368-378 
 
Tosca, L., Crochet, S., Ferré, P., Foufelle, F., Tesseraud, S., Dupont, J. (2006) AMP-activated 
protein kinase activation modulates progesterone secretion in granulosa cells from hen 
preovulatory follicles. J Endocrinol 190 (1), 85-97 
 
Tosca, L., Froment, P., Solnais, P., Ferré, P., F, F., Dupont, J. (2005) Adenosine 5′-
Monophosphate-Activated Protein Kinase Regulates Progesterone Secretion in Rat Granulosa 
Cells. Endocrinology 146 (10), 4500-45113 
 
Townson, D.H., O'Connor, C.L., Pru, J.K. (2002) Expression of Monocyte Chemoattractant 
Protein-1 and Distribution of Immune Cell Populations in the Bovine Corpus Luteum 
Throughout the Estrous Cycle. Biol Reprod 66(2), 361-366 
 
Tsai, S.J., Wiltbank, M.C. (1998) Prostaglandin F2alpha regulates distinct physiological changes 
in early and mid-cycle bovine corpora lutea. Biol Reprod 58 (2), 346-352 
 
Viollet, B., Guigas, B., Sanz, G.N., J., L., Foretz, M., Andreelli, F. (2012) Cellular and molecular 
mechanisms of metformin: an overview. Clin Sci 122, 253-270 
 
Walles, B., Gröschel-Stewart, U., Kannisto, P., Owman, C., Sjöberg, N.O., Unsicker, K. (1990) 
Immunocytochemical demonstration of contractile cells in the human ovarian follicle. 
Experientia 46 (7), 682-683 
 
Wiltbank, M.C., Belfiore, C.J., Niswender, G.D. (1993) Steroidogenic enzyme activity after 
acute activation of protein kinase (PK) A and PKC in ovine small and large luteal cells. . Mol 
Cell Endocrinol 97 (1), 1-7 
 
Wiltbank, M.C., Diskin, M.G., Niswender, G.D. (1990) Differential actions of second messenger 
systems in the corpus luteum. J Reprod Fertil Supplement 43, 65-75 
 
Wiltbank, M.C., Guthrie, P.B., Mattson, M.P., Kater, S.B., Niswender, G.D. (1989) Hormonal 
regulation of free intracellular calcium concentrations in small and large ovine luteal cells. Biol 
Reprod 41 (4), 771-778 
 
Wiltbank, M.C., Ottobre, J.S. (2003) Regulation of intraluteal production of prostaglandins. 
Reprod Biol Endocrinol 1 (91) 
 
Wiltbank, M.C., Shiao, T.F., Bergfelt, D.R., Ginther, O.J. (1995) Prostaglandin F2 alpha 
receptors in the early bovine corpus luteum. Biol Reprod 52 (1), 74-78 
 
Wong, A., Howie, J., Petrie, J., Lang, C. (2009) AMP-activated protein kinase pathway: a 
potential therapeutic target in cardiometabolic disease. Clin Sci 116, 607-620 
 
 87 
Wright, M.F., Bowdridge, E., McDermott, E.L., Richardson, S., Scheidler, J., Syed, Q., Bush, T., 
Inskeep, E.K., Flores, J.A. (2014) Mechanisms of Intracellular Calcium Homeostasis in 
Developing and Mature Bovine Corpora Lutea. Biol Reprod 90 (3), 55 
 
Yamamoto, D., Hayashi, M., Matsui, M., Miyamoto, A. (2004) PGF2α stimulates nitric oxide 
synthase (NOS) expression in endothelial cells co-cultured with luteinized, but not lutenizing 
granulosa cells: a possible implication of NO in acute blood flow increase during luteolysis. Biol 
Reprod 71 142 (Abstract 218) 
 
Yamashita, H., Kamada, D., Shirasuna, K., Matsui, M., Shimizu, T., Kida, K., Berisha, B., 
Schams, D., and Miyamoto, A. (2008) Effect of local neutralization of basic fibroblast growth 
factor or vascular endothelial growth factor by a specific antibody on the development of the 
corpus luteum in the cow. Mol Reprod Dev 75 (9), 1449-1456 
 
Yoshioka, S., Abe, H., Sakumoto, R., Okuda, K. (2013) Proliferation of Luteal Steroidogenic 
Cells in Cattle. PLoS ONE 8 (12) 
 
Zoller, L.C., Weisz, J. (1979) A quantitative cytochemical study of glucose-6-phosphate 
dehydrogenase and Δ 5-3β-hydroxysteroid dehydrogenase activity in the membrana granulosa of 
the ovulable type of follicle of the rat. Histochem 621 (2), 25-135 
